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Background: Cervical cancer remains the second most commonly diagnosed
cancer and the third leading cause of cancer death in developing countries.
Improving clinicians’ knowledge and understanding of surgical staging is critical in
the fight against the disease. Kenya has limited research on accurately predicting
the surgical stage following surgical treatment for cervical cancer.The uptake of
predictive mechanisms by gynecologists has not been common. Objective: To
assess prediction by comparing the odds ratios of three popular ordinal regression
models i.e. the Multinomial Logistic Regression (MLR) model, the Continuation
Ratio (CR) model and Adjacent Category Logistic (ACL) model when applying
cervical cancer data in surgical stage prediction. Method: We systematically
compared the performance of MLR, CR and the ACL as the predictive
mechanisms and evaluated the most appropriate model in the cervical cancer
setting. The study considered women who visited the Oncology department at the
Moi Teaching and Referral Hospital’s Chandaria Cancer and Chronic Diseases
Center and were diagnosed and surgically treated for cervical cancer from January
2014 to December 2018. Results and conclusion: We presented the comparison
between 3 different regression models for ordinal data within the cervical cancer
setting. We choose to carry out an inferential and a predictive approach. The
inferential approach found that the CR model without proportional odds yielded
better results when comparing the Akaike Information Criterion (AIC), log
likelihood ratio and residual deviance. In addition, the key prognostic factor
associated with invasive cervical cancer was the FIGO clinical stage which in
particular, had a higher influence on the surgical stage 2 outcomes compared to
the lesser surgical stage categories. All the 5 independent features selected for
classifying the patients into surgical stages were the FIGO clinical stage and
partly, the presence or absence of cancer of symptomatic vaginal discharge.
However, the predictive approach found that the MLR, CR and ACL models were
not statistically different and not suitable for the prediction of the surgical stage
among the women surgically treated for cervical cancer.
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This chapter discusses the motivation and background of the study, research
objectives and the significance of the study.
1.1 Motivation
Cervical cancer is the cancer that emanates from the cervix. The healthy normal
cells on the cervix are transformed into abnormal cells that multiply and invade
other parts of the body. Wilson et al. (2018) states that cervical cancer is the
leading cancer in Kenya among women of all ages with a crude incidence rate of
22.4 per 100, 000 persons and a crude mortality rate of 11.5 per 100, 000 in the
year 2017. Cervical cancer is caused by infection of the cervix by the human
papilloma virus. Petry (2014) clearly states that the persistence of the human
papilloma virus infection on the cervix causes oncogenic cell transformation at the
squamous columnar junction. In their article, Wilson et al. (2018) identified HPV
types 16 and 18 to be the most prevalent among women with a normal cytology,
low and high grade cervical lesions and those who progress to cervical cancer.
Nonetheless, cervical cancer is the best preventable malignancy of all relevant
human cancers with an increase in the establishment of cervical cancer screening
centers in middle and low income centers. Thus, Coleman et al. (2016) realized
that the introduction of screen and treat strategies for patients with abnormal
Visual Inspection with Acetic Acid (VIA) of the cervix has increased the number
of women screened and treated for cervical cancer in Kenya. Howbeit, with the
availability of HPV vaccines, the high costs limits their implementation in the
middle and low income countries leading to more access to surgical care than
chemotherapy and radiotherapy. Surgical treatment is among the curative options
given to women diagnosed with cervical cancer in the middle and low income
countries. The extracted specimen undergoes pathological assessment to determine
the full extent of the disease thus classifying the specimen into a surgical stage.
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Globally, the development and use of predictive models today is growing rapidly
and highly applicable in the health care sector for the provision of efficient care
and resources to patients. Moreover,James et al. (2013) defines predictive
modeling as the process of developing a mathematical model for predicting or
estimating an output based on one or more inputs and quantifying the accuracy of
the model to make future output predictions . Predictive models are developed
from statistically significant factors associated with the outcome of interest and
the models can range from complex to simple. Freedman et al. (2005) reports that
the National Cancer Institute had identified risk prediction as an area of
extra-ordinary opportunity in the ”Nation’s Investment in Cancer Research”. The
relevance of predictive modeling today in cervical cancer care is best summarized
in the words of Dr Micheal Rothberg:
“While HPV tests are very helpful in predicting cancer risk, other factors are just
as powerful at predicting cervical cancer risk. The more that we can personalize
risk prediction, the more efficient our screening efforts will become(Rothberg,
2018).”
The application of predictive modeling techniques in the early diagnosis and
prognosis of cancer has become a requisite to facilitate effective clinical
management of patients. Kourou et al. (2015) further support that machine
learning techniques aim to model the progression and treatment outcomes of the
cancer and improve our understanding of the disease thus resulting in accurate and
effective management of cancer patients. The authors acknowledge that machine
learning techniques could improve the accuracy of cancer susceptibility, recurrence
and survival prediction. The accuracy of predictive models is clearly asserted in
this statement by Kourou et al. (2015):
“The accuracy of cancer prediction outcome has significantly improved by
15%–20% in the last years, with the application of ML techniques.”
Predictive modeling methods identify patterns and their relationships in simple to
complex data sets. It involves the estimation of unknown statistically significant
independent variables from a particular data set and the estimated independent
variables are used to predict new outputs of the outcome of interest.
According to Powers et al. (2005), predictive models can be used to risk-stratify
patients and appropriately distribute resources such as caregivers and treatment
combinations to the women and also, identify women who are at high risk of
progression to clinical disease for disease management programs . Notably,
predictive modeling in the health sector has the potential to impact clinical and
therapeutic decision making.
This article gives an overview of 3 regression models developed for ranked data. It
is clear that the Cumulative Proportional Odds (CPO) model is the most popular
model and has naturally been utilized for analysis . However, due to the
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inflexibility of the proportional odds assumption, other regression models for
ordinal data have been developed that ease on the proportional odds assumption.
Generally, regression analysis investigates the influence of multiple predictors or
independent variables on a dependent variable or outcome. The assumption of
proportional odds in ordinal regression is that the effects of any explanatory
variables are consistent or proportional across the different categories. One of the
major shortcoming of Cumulative Proportional Odds(CPO)model is the
relationship between the predictors and the response variables that can be greatly
misleading when assumptions are violated.Theoretically, Wan Kai (2008) states
that a more recommended model for ordinal data would take into account the
categorical nature of the response since more information is contained within the
ordered structure of the categories. Wan Kai (2008) further asserts that ordinal
data is non-separable, independent , strictly increasing (decreasing) with arbitrary
cutpoints of some underlying continuum. Based on the pathologist’s point of view
i.e. the surgical stage in this study, the most vital prognostic factors were
presented and existing dissensions in the classification and diagnosis of the
extracted tumors clarified by 3 types of regression models. In this study, we seek
to assess 3 types of regression models for ordinal responses to predict the surgical
stage of HIV infected and uninfected women surgically treated upon being
diagnosed with cervical cancer. The 3 predictive mechanisms covered here have
previously been looked by Brant (1990); Christensen (2012); McCullagh (1980);
Winship and Mare (1984). Brant (1990) sought to assess the goodness of fit of the
proportional odds model for ordinal logistic regression. This particular model
represented a series of logistic regressions for dependent binary variables utilizing
common regression parameters (with the proportional odds assumption). Winship
and Mare (1984) stated that the methods for ordinal variables are considered
natural extensions of probit and logit models for dichotomous variables . Winship
and Mare (1984) asserts that such models explicitly recognize ordinality, avoid
arbitrary assumptions concerning the ordinal scales and allow for analysis of
continuous, dichotomous and ordinal variables within a common statistical
framework . Statistical packages such as lme4, nnet were developed to allow for
the implementation of cumulative link (mixed) models which are also known as
ordered regression models, proportional odds models, proportional hazards models
for group survival times and ordered logit/probit model. According to Christensen
(2012), estimation techniques were mainly via maximum likelihood . Through
extensions to non-linear models, McCullagh (1980) reports that the method of
iteratively reweighted least squares converged to the maximum likelihood estimate
which greatly simplifies the necessary computation of regression models for ordinal
data. Ananth and Kleinbaum (1997) give an excellent. Ananth and Kleinbaum
(1997) fully described statistical methods for modeling ordinal response data such
3
as the continuation ratio model, the polytomous logistic model among others with
application to perinatal health programme data.
1.2 Background to the study
1.2.1 Cervical cancer
According to the World Health Organization, cervical cancer is the fourth most
common cancer constituting 7.9% of the female cancers. Cervical cancer affects the
cervix (neck of the womb) which is the lower narrow part of the entrance to the
uterus(womb). The outer surface of the cervix connects the uterus to the vagina.
Figure 1.1 shows the position of the cervix in the female reproductive system.
Figure 1.1: Position of the Cervix in the female reproductive system(Australia, 2015)
The surface of the cervix is covered by two types of cells: Squamous cells which are
flat thin cells found on the outer part of the cervix that opens up into the vagina
(ectocervix) and glandular cells which are column-shaped cells found on the inner
surface of the cervix (endocervix). According to the Australian Cancer council, the
area where the squamous cells and glandular cells meet is called the
Squamocolumnar Junction (SCJ) and the area lateral to the SCJ is called the
Transformation zone. This is where most cervical cancers start. Nordqvist (2017)
explains that normal cells on the cervix have a set lifespan thus they die and are
replaced by new cells.However, in some women, the normal cells in the
transformation zone gradually change into abnormal cells (cells that do not die
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and keep dividing) which creates an area of abnormal tissue on the cervix called
pre-cancerous lesions that might turn into cancer. The terms usually used to
describe pre-cancerous cervical lesions include: cervical intraepithelial neoplasia
(CIN), squamous intraepithelial lesion(SIL) and dysplasia. According to the
American Society of Cancer (ASCO), only some women with the pre-cancerous
lesions will turn into true invasive cancer. However, for most women, the
pre-cancerous cells will go away without any treatment. The commonly known risk
factors associated with pre-cancer of the cervix and the gradual development to
invasive cancer are:
• Persistence of HPV infection which is sexually transmitted.
• Multiple sexual partners.
• Early onset of sexual activities.
• Smoking.
• A weak immune system as seen with the HIV infected women or women with
immune system related diseases.
• Multiple pregnancies.
• Sexually transmitted diseases such as Chlamydia.
In an article by the International Agency for Research in Cancer (IARC), the VIA
positive test outcome is termed invasive cancer of the cervix when there is a
clinically visible ulcero-proliferative growth on the cervix that turns densely white
after application of acetic acid and bleeds on touch. Histopathological examination
of a cervical biopsy provides a definite diagnosis of invasive cervical carcinoma. In
addition, imaging tests, clinical stage, type of cancer, age and parity at diagnosis
are vital to the choice of treatment. The main types of invasive cancer of the
cervix are squamous cell carcinoma and adenocarcinoma which are named after
the types of cells that become cancerous. According to Cancer Research UK,
70− 80% of every 100 cervical cancers have the involvement of the squamous cells.
Adenocarcinoma begins in the glandular cells that produce mucus which are
scattered within the endocervical canal. Adenocarcinoma is less common
compared to squamous cell carcinoma with 10 in every 100 cervical cancers.
Figure 1.1 clearly shows the location of squamous cell carcinoma development in
the skin-like cells that cover the outside of the cervix and adenocarcinoma
development in the glandular cells. In addition, the determination of the clinical
stage of cervical cancer depends on the size of the tumor. However, the invasive
physical check up for the tumor size and extraction of a biopsy for
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histopathological evaluation takes a trained medical professional. This is labor
intensive, time consuming and prone to errors.
Figure 1.2 shows the position of the SCJ on the cervix.
Figure 1.2: Position of the SCJ on the Cervix(Pradjatmo, 2015)
According to Atashili (2009), the psychological changes in the size and anatomical
position of the cervical SCJ may play a role in the age at which lesions occur. In
addition, he noted that the age at which lesions occur may also be related to the
age specific incidence, prevalence and persistence of HPV infection. Therefore, the
incidence of and mortality due to cervical cancer increases with age. Additionally,
in an article by Sangwa-Lugoma et al. (2011), the presence of high risk HPV is
associated with the woman’s behavioral and sexual characteristics which affect the
risk of new infections and immune function. Moreover, Chambuso et al. (2016)
states that the presence of HIV is highly significant to the progression of a HPV
infected woman to clinical disease due to the higher chances of recurrent HPV
infections. Abraham et al. (2013) discovered that the incidence of cervical cancer
among HIV infected women increased consistently with diminishing CD4+ count
leading to reduced immune function thus it is strongly evident that there is a
biologic relationship between HIV status and clinical disease outcome. In contrast,
since the introduction of antiretroviral therapy and the triple drug combinations,
HIV cannot be assumed to be solely involved in the oncogenic HPV progression to
clinical disease. Moreover, Denslow et al. (2014) discovered a gap in existing
literature on the effect of antiretroviral therapy on the progression to clinical
disease. Also, sexually transmitted diseases have been found by Sonia et al. (2017)
to be associated with high risk HPV infection and persistence with bacterial
vaginosis being a highly prevalent risk factor for acquisition and transmission of
many STI’s, including HIV and HPV.
The prevention and treatment of cervical cancer among HIV infected women is
described as complicated due to the weakened immune system increasing the risk
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of developing the disease. Moreover, other factors such as the history of sexual
activity, age at sex debut, lifetime sexual partners, sexually transmitted disease
history, prior cervical screening and the socio-demographic characteristics of the
women increase the complications of oncogenic HPV progression to clinical disease.
While the awareness and uptake of anti-retro viral medication has greatly
improved in Kenya, there seems to be increasing cases of cervical cancer among the
HIV infected women.
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1.2.2 Stages of Cervical Cancer
According to the American Cancer Society 2018, clinical staging gives an estimate
of the extent of the cancer. Clinical staging is done on initial diagnosis and prior
to any treatment plan being assigned. It is based on a visual and physical
examination of the cervix by an experienced gynecologist, imaging tests such as
MRI, CT and PET scans, cervical histology results and blood tests. Heaps and
Berek (1990) state that CT scans are perhaps the best technique for cervical
cancer evaluation as it can assess the primary tumor, urinary and gastrointestinal
tracts, liver parenchyma and the retroperitoneum. A clinical stage of a cancer does
not change overtime. For instance, the information that would be added to the
initial clinical stage if the cancer spreads to the bone is bone metastasis. Clinical
staging is considered vital to aiding in treatment plan decision making and as a
baseline when assessing how the cancer responds to treatment. Moi Teaching and
Referral’s Chandaria Cancer and Chronic Diseases Center use the FIGO staging
system. The overall clinical stage of a cervical cancer is determined by the primary
tumor size, the grade of the cancer, lymph node involvement and metastasis of the
cancer. The grade refers to the differentiation of the cells of the cervix. Low grade
or well differentiated cervical cancer displays cervical cells that look like normal
cells from a normal tissue and the cancer gradually grows. High grade or poorly
differentiated cervical cancer displays cells that appear very different from normal
cells, grow quick and give a worse outcome. It is stated that whenever the grade
does not affect the cancer’s stage, it may still affect the outlook and / or the
treatment plan. Moreover, Heaps and Berek (1990) state that CT scans are
perhaps the best technique for cervical cancer evaluation as it can assess the
primary tumor, urinary and gastrointestinal tracts, liver parenchyma and the
retroperitoneum. However, this study is limited to recorded clinical data since the
molecular scale data based on imaging is expensive and unavailable for analysis.
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Figure 1.3 clearly shows the spread of the cancer from the cervix as the tumor
increases in size.
Figure 1.3: Pictorial presentation of the various stages of cervical cancer(Vinci,
2014)
The early cervical cancer tumors which are confined to the cervix include carcinoma
in situ (stage 0), stage 1A , stage 1A1 , stage 1A2 , stage 1B and stage 1B1 tumors.
The locally advanced cervical cancer tumors are stage 1B2 , stage 2 , stage 2A ,
stage 2B , stage 3 , stage 3A , stage 3B and stage 4A with stage 4B tumor being
advanced cervical cancer which has spread to organs away from the cervix such as
the lungs.
1.2.3 Treatment of Invasive Cancer
The main treatments offered at the Chandaria Cancer and Chronic diseases Center
are surgery and chemotherapy with referrals being offered for radiotherapy
treatment. Surgery involves the removal of the tumor and the tissues or organs
around the tumor. The main surgical treatments given are cone biopsy which
involves removal of a cone-shaped tissue of the tumor and a small area of the
surrounding tissue, simple hysterectomy which involves the removal of the cervix
and some pelvic lymph nodes, radical hysterectomy which involves the removal of
the cervix, womb, fallopian tubes, the parametrium, the top of the vagina and
lymph nodes and radical trachelectomy which is the removal of the cervix,
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parametrium, upper part of the vagina, the pelvic lymph nodes with the womb
and ovaries left intact to enable the woman to conceive.
The International Agency for Research in Cancer explains that radical
radiotherapy involves the use of x-rays to kill the cancerous cells. External
radiotherapy is administered from outside the cervix and brachytherapy or internal
radiotherapy is administered from inside the cervix. Moreover, chemotherapy
involves the use of drugs given through a drip into the vein to kill the cancerous
cells. Chemotherapy is classified as either neoadjuvant chemotherapy or adjuvant
chemotherapy. If the purpose of the treatment is to shrink the tumor to ease
removal or increase the effectiveness of radiotherapy, then neoadjuvant
chemotherapy treatment is given before surgery or with radiotherapy. If the
purpose of the treatment is to kill any remaining cancer cells after surgery or
radiation, then adjuvant chemotherapy treatment is given. Furthermore,
chemoradiation treatment can be given which involves using a combination of
chemotherapy and radiation.
Surgical treatment options at the Moi Teaching and Referral’s Chandaria Cancer
and Chronic diseases Center are given to women who present clinical stages
1A − 2A1 inclusive of carcinoma in situ. The recommended surgical treatment
options for invasive cervical carcinoma are LEEP, cone biopsy, radical
trachelectomy (to maintain fertility), simple (total) hysterectomy and radical
hysterectomy. Upon completion of a surgical procedure, the extracted tissue
undergoes surgical staging to fully assess the extent of the disease. This is a vital
process as it allows for informed decision making in regards to additional
treatment options such as chemotherapy, radiation or a combination of treatments.
Moreover, surgical staging gives precise information on treatment response and
prognosis. The surgical staging involves determining the size of the primary tumor,
its location, assessing metastasis into the lymph nodes and assessing for other
tumors. Besides, Matsuo et al. (2015) states that depending on the pattern of
surgical risk factors obtained from the surgical specimen, patients with an
increased risk of recurrence are assigned post-operative therapy. For the surgically
treated patients, Matsuo et al. (2015) lists the high risk surgico-pathological
factors to include pelvic lymph node metastasis, parametrial involvement and
positive surgical margins whereas the intermediate risk factors include large tumor
size, lymphovascular space invasion, and deep cervical stromal invasion. Pecorelli
and Odicino (2003) considered that surgical and pathological data are vital for
precise analysis of survival and prognostic risk factors. Thus, the surgical stage
provides additional and clearer information to determine a woman’s prognosis.
The aim of the study was to evaluate the significance of the surgical stage to the
choice by the gynecologist to surgically treat a patient based on the clinical stage
and key predictive factors at the MTRH’s CCCDC Oncology department. Figure
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1.4 is the conceptual framework for this study which is informed by Drolet et al.
(2013) who were interested in the risk of cervical cancer based on the inequalities
of women in different socio-economical groups and sexual behaviors.
Figure 1.4: Conceptual framework of the different pathways linking
sociodemographic characteristics and HPV-related conditions(Drolet et al.,
2013).
Currently, clinical prediction to diagnose and treat cervical cancer is mainly done
through observation, intuition, experience and wisdom. The status of a patient
following the prescribed treatment is always associated with the treatment. In
contrast,Rosenfeld and Breslow (2008) found that treatments that were ineffective
or deleterious were perpetuated because there was no basis for determining
whether there was a cause and effect relationship between the treatment and the
result. It has become vital to better understand the causal connection between
treatment and the clinical outcome so as to accurately assess the improving or
deteriorating status of a patient on or after treatment. By utilizing inferential
techniques, support systems have been created to assist doctors and clinicians
detect associations in medical data and observe patterns that may be life
threatening to patients. However, effective treatment of cervical cancer among the
HIV infected and uninfected women in a predictive manner and the ability to
automate the best treatment plan warrants investigation in Kenya.
1.2.4 Machine Learning
James et al. (2013) define machine learning as an extensive set of tools for
understanding data. The tools are categorized as supervised learning and
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unsupervised learning tools. This study utilized the supervised learning tools
which involve building a statistical model for predicting an outcome based on one
or several predictor variables. The machine learning problem in this study is a
classification problem. That is, the predicted outcome is a qualitative or
non-numeric value. Classification is synonymous with pattern recognition.
Classification involves identifying the class or category to which a new observation
belongs, based on a training set of observations whose class membership is already
known. Classification can be categorized into binary classification and multiclass
classification. Binary classification involves only two possible classes whereas
multiclass classification involves three or more classes. Machine learning algorithms
perform predictions and learn from large sets of data. An algorithm that
implements classification is referred to as a classifier and assigns a clinical outcome
based on the observed attributes. The performance of a classifier is evaluated by
various factual tests. Precision is the conventionally used performance metric test
to determine the quality of a classifier. Machine learning is an extension of
predictive modeling. Thus, in this study, machine learning was utilized to predict
the surgical stage of the cervical disease after surgical treatment.
Predictive Modeling
The model of choice should accurately predict the expected surgical outcome
following surgery. However, interest lies in the accuracy of the predictions that are
obtained when the machine learning tool is applied to unobserved data. Using
data from the past four years of diagnosed cervical cancer patients, we can train
the machine learning method (algorithm) to predict the surgical stage following
surgical treatment based on clinical measurements. Cousins et al. (2002) states
that a classifier will enable women to be risk-stratified to identify opportunities for
intervention prior to the occurrence of adverse outcomes thus leading to efficient
resource allocation with cost-effectiveness and successful treatment of cervical
cancer. In the health sector, predictive models are applied to patient medical data
and the outcomes utilized to help with decision making on interventions such as
drugs, physicians, treatment plans among others.
Cancer care revolves around prediction of the prognosis prior to treatment. In
their article, Seel et al. (2012) state that empiricaly based, probabilistic models
were more accurate than the subjective clinical judgements in predicting health
outcomes and also, by generating empirical, quantitative estimates of the
likelihood of an outcome, prediction models can improve accuracy. According to
Vickers (2011), prediction models estimate the probability of future events. The
absence of symptoms in early stage cervical cancer patients has limited treatment
and recommendations to be based on the fact that tumor progression would
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eventually threaten a patient’s morbidity. Vickers (2011) affirms that the
establishment of statistical tools has provided a quantifiable probability estimate
of an outcome for each patient. Moreover, the author asserted that prediction
models have greater accuracy compared to clinical staging or risk grouping,
integrate novel predictors and enable intelligent informed - based treatment
decisions. He concluded that prediction models should be used in cancer care
decision making with integration into the electronic health records and careful
evaluation of model’s clinical outcomes.
While it is clear that predictive models are vital in determining treatment plans
for patients with chronic diseases, Rosenfeld and Breslow (2008) states that
“‘it would be desirable to monitor the progress of the patient using predictive
models to evaluate the effectiveness of the treatment plan on a continuous basis
and to revise the treatment plan and /or the patient specific rules accordingly.”
For instance, Biewenga et al. (2011) was able to show that disease-specific survival
(DSS) in patients with early stage cervical cancer can be predicted with a
statistical model. Upon the correction of the 9% over fit shown by bootstrap
internal validation, the formula for the multivariate prognostic model to calculate
the DSS at a particular time x is shown below:
5− (year)DSS(tx)
= basicsurvival(tx)exp(β0(tx) + 0.91((0.02 ∗ TD) + (1.6 ∗ AC) + (0.46 ∗ ASC) + (1.2 ∗ LNM) + (0.24 ∗DI) + (0.85 ∗ LV SI) + (1.08 ∗ PMI)))
(1.1)
The accuracy of this particular model to make predictions was done by
comparing the predicted and observed DSS at 5 year follow up. The area under
the receiver operating characteristic (ROC) curve, the sensitivity and specificity
were calculated to assess the ability of the model to correctly classify the patients
with DSS. The authors found that after correction by a shrink factor of 0.91, the
independent and statistically significant predictors used in the multivariate model
were the tumor diameter (TD), histological type (either AC for adenocarcinoma or
ASC for adenosquamous cell carcinoma), presence of lymph node metastasis
(LNM), depth of stromal invasion in millimeters (DM), lymph vascular space
invasion (LVSI) and parametrial invasion (PMI). Another example of a predictive
model is by Yuri et al. (2016) who designed a prostate cancer risk calculator to
predict the risk of prostate cancer by use of chi-square
analysis,Kolmogorov-Smirnov test, multiple logistic regressions and the receiver
operating characteristic (ROC) curve. The authors found that age, prostate
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volume, serum prostate specific antigen (PSA), digital rectum examination finding
and family history are factors associated prostate cancer.The four parameters
associated with the predictors PSA, age, prostate volume and digital rectum
examination are Lpsa which is the log2(PSA), lpsac the mean value of the
log2(PSA), Lvol the log2(prostate volume) and lvolc the mean value of log2(vol)
The predictive equation or logistic model developed is shown below:
Ln(odds) = β0 + β1(lpsa− lpsac) + β2(lvol − lvolc) + β3(lage− lagec) + β4(DRE) + β5(HY S)
(1.2)
1.3 Problem statement
We aspire for all the women attending the Oncology department at the Chandaria
Cancer and Chronic Diseases center for cervical cancer treatment be given the most
effective treatment upon confirmed diagnosis for the best possible outcomes. Today,
there are women with cervical cancer who have their treatment regimen changed
while undergoing treatment due to the ineffectiveness of the initial regimen. This
problem leads to wastage of valuable patient time and resources resulting in costly
treatment and low survival rates. Therefore, we have described, illustrated and
compared the odds ratios of 3 regression models for ordinal responses to predict the
surgical stage of HIV infected and uninfected women surgically treated for cervical
cancer. Furthermore, we seek to determine the most appropriate model for the
cervical cancer data at the Oncology department.
1.4 Objectives of the Study
The general objective of the study is to assess efficient risk ratios by predicting the
surgical stage outcome of women surgically treated for cervical cancer. The specific
objective of the study
1. To develop, validate and compare the odds ratio of 3 types of regression
models for ordinal responses which include the Continuation Ratio model,
the Adjacent Category model and the Polytomous (Multinomial) logistic
model.
1.5 Research Questions
The surgical outcomes in this study are surgical stage 0, surgical stage 1, surgical
stage 2 and surgical stage 4. The ultimate objective is to assess prediction in terms
of the odds ratio by answering the question: Among the three regression models for
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ordinal responses, which model best estimates and predicts the surgical stage prior
to surgical treatment of cervical cancer?
1.6 Scope of the study
The main focus of this study was to develop, validate and compare the odds ratios
of 3 types of regression models for ordinal responses to predict the surgical stage of
HIV infected and uninfected women surgically treated for cervical cancer in the
Oncology department at the Chandaria Cancer and Chronic diseases center based
in Eldoret, Kenya. Retrospective complete medical records collected from women
who had been diagnosed with oncogenic HPV infection and had progressed to
clinical cervical cancer disease from January 2014 to December 2018 were retrieved
and analyzed to develop the predictive models. This particular time period was
chosen as the data was readily available. The explanatory variables considered
were the socio-demographic characteristics such as age, bmi, occupation,
parity,sexual behaviors such as use of contraception, clinical and pathological
variables such as symptoms, method of detection, confirmed histology result,
clinical stage, tumor size or grade, lymph node metastases, parametrial
involvement, treatment plan and follow up visits information which include uptake
of radiation, chemotherapy and recurrence of disease.
Limitations of the Study
To begin with, the study is limited by the use of an existing data set with a small
sample of women who underwent surgical treatment and the utilization of 3 response
categories which is considered the simplest extension of the binary logistic model .
The data utilized was not specifically collected to develop predictive models or for
predictive purposes. Secondly, the quality of the data was briefly addressed through
data cleaning. Thirdly, the presence of bias was due to the fact that the available
data was based on human memory and human error. Finally, the data may not
reflect the actual extent of the prevalence of cervical cancer within Kenya since
there are other fully operational institutions that offer cervical cancer treatment
within and without Eldoret town. In conclusion, further research should be carried
out in the future with a larger sample size to allow for cross validation techniques.
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1.7 Significance of the study
The study will bring awareness to this particular oncology team on the possible
key predictors and informed decision making of surgical treatment candidacy
leading to proper and specific types of information being collected from patients
with invasive cervical cancer. Secondly, encourage more research on algorithms
that can aid with future prediction on possible outcomes thus enabling better
utilization of the available resources to maximize patient benefits whilst
minimizing the risk. Thirdly, the results from the study will create opportunities
for the establishment of low cost modalities for evaluation of disease extent to
reduce morbidity and save on resources such as pre-treatment surgical staging
techniques. Fourthly, the study outcomes will increase early detection of cervical
cancer by opening of fully operational national cervical cancer screening clinics
with highly trained doctors, clinicians, nurses , variety of up to date screening
techniques (for example pap tests, visual inspection methods, liquid based
cytology, DNA HPV tests, laparoscopy and lymphadenectomy among others) and





Although surgical staging has provided data on the frequency of para-aortic lymph
node metastasis by stage of cervical cancer and led to better treatment strategies,
Heaps and Berek (1990) report that high rates of pelvic and systemic failure during
surgical staging has produced an unexceptional boost in survival rates. However,
in comparison to surgical staging, Gold et al. (2008) report that clinical staging is
60% accurate. Currently, cervical cancer remains the only gynecologic malignancy
that is staged clinically. Gold et al. (2008) report that the clinical staging errors
are associated with misdiagnosed lymph node metastasis. In order to estimate the
absolute probability of risk for specific individual outcomes, studies have shown that
different types of information on an individual at a given time can be utilized which
leads to the establishment of prognostic or prediction models. Huang et al. (2010)
mention that mathematical modeling applications can improve outcome predictions
of cancer therapy. In the healthcare environment, predicting a condition based on
clinical characteristics, observation and wisdom forms the basis of treatment given
to cancer patients. However, increasing technological advancement, improvement
in global health care and the diverse treatments given to cancer patients have led
to the need for doctors and clinicians to recognize and deal with the challenges of
effective diagnosis and treatment of cancer. The following review of literature is
to determine the usability of predictive tools prior to surgical treatment of cervical
cancer in the oncology health care system.
2.2 Defining the problem
According to the World Health Organization, cervical cancer screening aims to
detect pre-cancerous changes which, if not treated, may lead to cancer.
Additionally, it was noted that the availability of effective treatment among
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women 30− 49 years of age is not being captured. Based on the 2030 Agenda for
Sustainable Development and its 17 Sustainable Development Goals, good health
and well-being is one of the goals to transform our world. The Gynecologic
Oncology Group assert that surgical staging has been a required method of aortic
lymph node evaluation. During surgery, the gynecologists decide on the best
treatment for the patient upon examining the actual extent of the disease.
Furthermore, the cancer is categorized into stage 1, 2, 3 or 4. Bhatla et al. (2019)
consider pathological confirmation as the gold standard for surgicopathological
assessment of lymph node involvement in surgically treated patients. At most,
surgically staging for cervical cancer patients is done prior to therapy assignment
through laparotomy or laparoscopy surgical procedures.
Marnitz et al. (2005) state that the FIGO clinical staging of cervical cancer is
associated with a high percentage of over and under staging the tumor extent. The
authors discovered that laparoscopy transperitoneal staging procedure provided
more information on the actual extent of cervical cancer disease prior to surgery.
Marnitz et al. (2005) studied 84 patients with cervical cancer FIGO stage I to
stage IV and found that the clinical stages were underestimated for 87% of the
cases with the distribution of the clinical stages according to FIGO as follows:
stage IB1 in 15.5%, IB2 in 15.5%, IIA in 8.3%, IIB in 23.8%, IIIA in 8.3%,IIIB in
21.4%, IVA in 6%, and IVB in 1.2%. Pathological findings following laparoscopic
staging in 43% of the patients had a higher tumor stage diagnosed. However, the
laparoscopic approach is expensive and not readily available at the Oncology
department at the MTRH’s Chandaria Cancer and Chronic Diseases Center.
In addition, Prasad et al. (2014) postulate that the major limitations of FIGO
clinical staging of cervical cancer are the discrepancies with surgical staging and
the inability to assess the lymph nodes. Moreover, the authors state that the
FIGO clinical staging system results in under or over-staging in 20 − 40% of
patients when compared with surgical staging. Prasad et al. (2014) carried out a
literature review and found that CT imaging does indeed improve the accuracy of
clinical staging performed by FIGO guidelines. In their study, Prasad et al. (2014)
sought to determine the differences between clinical and CT staging based on data
from 53 patients with cervical carcinoma prior to any treatment. A McNemar test
determined that the difference between FIGO and CT staging was significant
(P< 0.001 ) . Moreover, a Kappa value of 0.08± 0.06 suggested a poor consistency
between the two staging techniques. The CT scans were visible in 70% of the
patients. Vaginal involvement was seen in 61.5% of the patients during clinical
examination with 41.5% being consistent in the evaluation of parametrial invasion.
Additionally, unilateral pelvic involvement, bilateral involvement, pelvic nodes
involvement and retroperitoneal nodes were seen in 26.4%, 32%, 20.7% and 11.3%
of patients. Thus, CT imaging being the less cheaper and widely available option
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in developing countries, Prasad et al. (2014) findings support that CT imaging
does not reliably correlate with clinical FIGO staging of cervical cancer.
Nonetheless, the MRI/CT scans tend to be costly for most women attending the
oncology treatment clinics particularly in the Kenyan health sector. At most, the
patients are required to have CT imaging upon histological diagnosis of the cancer
and after surgery to determine the need for further therapy. Moreover, the records
of the CT images are not kept in the oncology databases.
Surgical evaluation allows for the stratification of patients based on the extent of
the cervical carcinoma. Fader and Rose (2007) state that a surgical procedure is
primarily for the establishment of a diagnosis, determine the disease extent and
remove as much of the gross tumor. Averette et al. (1972) evaluated the
laparotomy procedure for surgical staging prior to cervical cancer treatment. The
authors discovered that clinical staging was not accurate in 38.6% of the patients
and 14.3% had aortic lymph node metastasis. Therefore, they concluded that
surgical staging greatly modified therapy whether primary therapy was by radical
operation or radiology. Moreover, the purpose of staging according to Derks et al.
(2016) is to assess the surgical treatment outcome in terms of patient recurrence
patterns and survival. By applying the Kaplan-Meier technique on 129 women
treated by radical hysterectomy with pelvic lymphadenectomy for stage 1B2 /
2A2, Derks et al. (2016) found a disease-specific survival of 84%. Also, by carrying
out univariate and multivariate analysis, the authors realized that the histologic
type, tumor diameter and the parametrial involvement were key prognostic factors
associated with patient survival. Thus, 50% received adjuvant treatment and a
pelvic recurrence rate of 8% was noted.
Additionally, Rutledge et al. (2004) sought to define predictive factors of nodal
status and recurrence in 109 and 86 patients with stage 1B1 and 1B2 cervical
cancer respectively treated with radical hysterectomy. Multivariate analysis via
stepwise logistic regression identified lymphovascular space involvement (OR 6.4,
CI 2.4 − 17, P = 0.0002) and parametrial involvement (OR 8, CI 3.1 − 20, P
= 0.0001) as independent predictors of positive nodes. Kaplan-Meier technique
was applied to evaluate the Disease Free-survival post-surgery and established that
lymphovascular space involvement (ROR 5.7, CI 2− 16, P = 0.0064) and outer 2/3
depth of invasion (OR 5.8, CI 2− 20, P = 0.0029) were the independent predictors.
Based on their analysis, Rutledge et al. (2004) deduced that these factors were
best determined post-surgery and that treatment decisions based on tumor size
only should be reconsidered.
In support of Rutledge et al. (2004), Qin et al. (2009) inferred that for operable
cervical cancer, the clinical stage on its own is not well grounded for the selection
of post operative therapies. Since cervical cancer is the only gynecological cancer
that is staged clinically and not pathologically, Qin et al. (2009) sought to analyze
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the discrepancies between the clinical stage (accuracy of the physical pelvic
examination) and the pathological result. They analyzed 818 women with
confirmed stage 1B to 2B cervical carcinoma treated primarily with surgery. The
women were assigned to pT category based on the pathological findings. The
authors noted absolute consistency of 53.1% between the clinical stage and pT
category for stage 1B to 2B with a 37.3% over estimation and 9.7%
underestimation. The consistency in stage 1B1, 1B2, 2A and 2B were found to be
85.4%, 77.4%, 35.3% and 20.5% respectively. In contrast, they found that the most
significant inconsistency was in the accuracy of clinical staging to determine
vaginal and parametrial disease which was at 70.2% and 74.0% respectively. In
their conclusion, Qin et al. (2009) suggested that a surgical staging system ought
to be put into consideration for operable cervical cancer tumors. Earlier on, van
Nagell Jr et al. (1971) expressed that the most common error was failure to
accurately define the extent of parametrial disease by clinically staging cervical
carcinoma patients. van Nagell Jr et al. (1971) had retrospectively investigated the
inevitable discrepancies between clinical staging and pathological findings in 370
women who were evaluated, staged and treated for invasive cervical carcinoma.
There was decreasing clinical stage accuracy for stage 1 to stage 2 at 78% to 25%
with only 66% of women found to have been clinically staged accurately.
While the clinical stage of cervical carcinoma is very helpful in predicting the
tumor size, the vaginal and parametrial involvement, surgical staging can provide
further vital information that can impact therapy. Sayed (2019) wrote that the
next step in pathology is machine learning. At the level of cancer diagnosis,
pathologists are accurate; however, when predicting the development of cancer,
Sayed (2019) reports that the accuracy rate is at 60%. Currently, machine learning
is headed towards developing a high accuracy pathology system in cancer
care.Although Kenya is far from attaining low-cost technology for microarray
expression, Chen (2012) carried out a study whereby he compared ordinal and
non-ordinal algorithms on 5 cancer stage microarray datasets. By utilizing only
the predictive genes to model the cancer stage, the author concluded that a strict
ordinal classifier trained by a validated approach can more accurately predict the
cancer stage compared to non-ordinal classifiers without considering the order of
the stages.
2.3 Searching for solutions
The surgical stage has been found to clearly differ from the determined clinical stage
at diagnosis. For instance, when surgery shows that the cancer has spread more
than was perceived during the preoperative staging. According to Lagasse et al.
(1980), the Gynecologic Oncology Group (GOG) confirmed that clinical staging is
20
often inaccurate in determining the extent of disease in cervical cancer patients.
The authors arrived at this denouement in a multi-institutional study where 29%
of patients with stage 2, 3 and 4 had paraaortic nodal metastases which did not
correlate with the histologic grade of the tumors. Chow et al. (2008) states that a
predictive model has the potential to lead to improvement in delivery of care and to
minimize under treatment or over treatment. Based on 207 stage 1B - 2A cervical
cancer patients, Sun et al. (2011) developed a multivariate logistic regression model
to predict lymph node metastasis. The logit model 2.1 was a proposed model to
improve conservative surgery for patients with early stage cervical cancer.
Equation 2.1 was the model that was developed with a predictive accuracy of 76.3%:
Logit(p) = −2.534 + SerumSCCAg ∗ 1.934 + Depth of cervical stroma ∗ 0.801 (2.1)
The SerumSCCAg and depth of cervical stroma were found to be the independent
risk factors of pelvic lymph node metastasis in early stage cervical cancer.
Under surgical treatment, radical hysterectomy with parametrectomy is the
treatment for early stage cervical cancer. Hsu et al. (2018) report that even
though the prognosis is good, parametrectomy damages the autonomic nerve and
bladder functions leading to a poor quality of life. In order to improve the quality
of life for eligible radical hysterectomy patients, Hsu et al. (2018) carried out a
retrospective study on 339 women with class II − III radical hysterectomy to
develop an algorithm based on the factors predictive for possible parametrial
invasion in early cervical cancer. The authors aim was to facilitate radical
hysterectomy patient selection among those who have been recommended for
parametrectomy. The authors applied the non - parametric chi-square test, the
Krustal - Wallis test and the Mann - Whitney U test on the categorical and
continuous variables. They proposed two frameworks based on either the frozen
pathologic sections of the pelvic lymph nodes or the patient’s age to determine
whether parametrectomy is recommended.
Figure 2.3 recommends sentinel lymph node sampling with frozen pathology prior
to surgery. There are higher incidences of parametrial invasion among patients
with lymph node metastasis (25%(4/16) stage 1B1,p < 0.001, chi - square test)
and a tumor size ≤ 2cm.
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Figure 2.1: Determination of the need for parametrectomy during radical
hysterectomy based on the status of pelvic lymph node metastasis (Hsu et al., 2018).
Figure 2.3 recommends radical hysterectomy prior to surgery for all patients aged ≥
50 in facilities that without resources to perform sentinel lymph node sampling. The
authors found that 9.7%(6/62) of the patients aged over 50 years had parametrial
invasion.
Figure 2.2: Determination of the need for radical parametrectomy during
hysterectomy based on patient age.
Pathological evaluation post surgery allows for optimal benefit and minimal risk in
terms of patient survival and disease recurrence. Kamura et al. (1992) maintain
that based on prognostic findings, the prediction of post surgery prognosis is more
precise compared to clinical staging. Kamura et al. (1992) applied multivariate
analysis using cox regression models on 345 patients with stage IB − III cervical
cancer who had undergone radical hysterectomy and pelvic lymphadenectomy.
The authors discovered that the key independent and prognostic factors on the
survival of the patient post surgery were the histologic subtype, longitudinal tumor
diameter and pelvic lymph node metastases. Furthermore, Gold et al. (2008)
multivariate analysis on 555 surgically sampled and 130 radically evaluated using
CT, MRI or lymphangiogram for para-aortic lymph node metastasis. Gold et al.
(2008) established that there was poorer prognosis on the radically evaluated
patients compared to the surgically staged patients. In this case, the multivariate
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analysis was adjusted for age, race, performance status, histology, tumor size and
extent of parametrial involvement. The authors found that the relative risk of
disease progression in the radically evaluated compared to the surgically staged
was 1.35(95%CI[1.01 − 1.81], P = 0.043) and the relative risk of death was
1.46(95%CI[1.08− 1.99], P = 0.014).
Predictive models have been successfully applied to other cancerous diseases such
as prostate cancer. Partin et al. (1997) developed a multi-institutional model
based on 4133 men treated by radical retropubic prostatectomy for clinically
localized prostate cancer. The authors carried out a multinomial log-linear
regression to concurrently predict organ-confined disease, isolated capsular
penetration, seminal vesicle involvement and pelvic lymph node involvement.
Then, bootstrap estimates of the predicted probabilities were used to develop
nomograms to predict the pathological stage of the disease. The performance of
the nomograms were validated by applying bootstrap analysis. Prostate-specific
antigen level, TNM clinical stage and the Gleason score were found to be
statistically significant factors for the prediction of the pathological stage with
P-values< 0.001. The validation pathological stage outcomes of the predictive
model were 67.3% organ-confined disease, 59.6% isolated capsular penetration,
79.6% seminal vesicle involvement and 82.9% pelvic lymph node involvement.
Thus, Partin et al. (1997) proposed that the nomograms would enable physicians
and patients to make more informed based decisions and individual patient
counseling based on the probability of the tumor being at a particular stage.In
support of predictive models, Gancarczyk et al. (2003) developed probability
nomograms for pathological stage outcome at the time of radical prostatectomy for
1, 510 men. Univariate and multivariate logistic regression analysis established
that pretreatment PSA, highest biopsy Gleason sum and the percentage of cores
positive for cancer were the most significant independent predictors of pathological
stage. Moreover, Partin tables have been developed to predict the pathological
stage at radical prostatectomy. A table for clinical unilateral T3a prostate cancer
patients was developed by Joniau et al. (2007) based on preoperative prognostic
factors of 200 men with the disease who underwent a radical prostatectomy and
bilateral pelvic lymphadenectomy. The authors applied the multinomial log-linear
regression analysis and found that 3 subgroups of PSA and 2 subgroups of biopsy
Gleason sum allowed for patient stratification into 6 demarcated risk groups. The
authors determined that the table could provide a basis for informed decision
making and counseling of patients prior to surgery.
Regression models for ordinal responses take into consideration response variables
with more than 2 categories and have some form of ordering. The work of Buch
et al. (2005) on the effects of model choice on the relative risk estimates of blood
cancer concluded with the continuation ratio model being best fit for the ordinal
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data in their study. The authors performed a case-control study to determine
whether the estimated relative risks would vary when the multinomial, cumulative
logit and continuation ratio models were applied to 4 response levels. These levels
were non-blood cancer (controls), organ confined non-aggressive bladder cancer
cases, organ confined aggressive bladder cancer cases and non-organ confined
aggressive bladder cancer cases. Similar results were obtained by the multinomial
logistic regression model compared to the multiple binary models. The cumulative
logit model and the continuation ratio model gave different parameter estimate
interpretations with the CR model being considered best fit based on the
goodness-of-fit statistics, the regression diagnostic analysis, smaller standard errors
and smaller 95% confidence intervals. Buch et al. (2005) stated that
polychotomous logistic regression models are extensions of binary logistic models
that preserve the natural order of outcomes with more than 2 categories, maximize
the use of the available information in the categories, concurrently allow multiple
logits to be estimated for nominal response variables, more statistical power is
attained and estimators obtained are more efficient.
de Jong et al. (2019) presented a full-factorial simulation study to examine the
predictive performance of the MLR models in relation to the relative size of the
outcome categories, number of events and the number of events per variable. The
authors carried out a study on ovarian cancer by applying penalized and
unpenalized MLR to a development set (N = 2049) and a validation set (N
= 2799) from a clinical study to produce a clinical prediction model. The model
was to predict whether an ovarian tumor is benign, borderline malignant or
invasive. de Jong et al. (2019) stated that due to the possibilities of invasive
treatments worsening the prognosis of the ovarian cancer, it was vital to choose the
most appropriate treatment using non-invasive procedures. The predictors of
interest were age in years, presence of papillations with blood flow (yes/no),
irregular cyst walls (yes/no), presence of acoustic shadows on the echo (yes / no),
presence of ascites in the pouch of douglas (yes / no) and maximum diameter of
solid component (continuous but no increase > 50mm). The authors utilized
maximum likelihood, lasso and ridge to estimate the MLR models with the
baseline category considered to be benign tumors. It was determined that in
practice, the MLR model estimated by maximum likelihood tend to overfit even in
samples with a high number of multinomial events per variable. Moreover, the
authors discovered that the predictive performance of a MLR is affected by the
sample size, analysis technique (whether or not shrinkage techniques are applied)
and the relative size of the outcome variables.
According to de Jong et al. (2019), the calibration of the MLR models was at its
worst when all outcome categories were equal in size, the multinomial events per
variable was small and the number of predictors were low. However, when the
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multinomial events per variable was constant, model calibration improves as at
least one of the outcome categories grows in size and as the number of predictors
increases. The finding supports that as sample size affects the predictive
performance , it affects the MLR model calibration. Additionally, the MLR
estimated by ridge and lasso gave better calibration compared to the MLR
estimated by maximum likelihood. Penalization reduces the overfit of estimates by
inducing a small bias thus reducing the variance of the estimated probabilities.
Improvement in calibration enhances the overall performance of the MLR
model.de Jong et al. (2019) concluded that the predictive performance of a MLR
model is very much related to the multinomial events per variable and the total
sample size. When the total sample size is low, predictive performance can be poor
and when the multinomial events per variable is below 10, the MLR model
becomes at risk of serious miscalibration.
According to de Jong et al. (2019), the lasso MLR is applied to highly correlated
predictors as performance increased significantly with increasing correlations. For
the ridge MLR, correlation between predictors stabilizes the estimates, lowers the
number of effective degrees of freedom as the coefficients are shrunk and improves
the overall predictive performance.For the maximum likelihood MLR, when
correlation changed, the ratio of events per effective degrees of freedom utilized
remained constant which, in their study, may explain the small change noted in
the model’s predictive performance. The authors concluded that the MLR
prediction model performance is related to multinomial events per variable and the
total sample size and should be considered during development of the prediction
model. Clearly, when the total sample size In addition, the work of Dos Santos and
Berridge (2000) expounded on reasons a continuation ratio framework could
ultimately be better than the multinomial and adjacent category logit models. The
authors presented methods of analysis for ordinal repeated measures by
investigating the influence of a group of explanatory variables on the overall
condition of patients treated for breast cancer. The ordinal responses which were
the patient’s overall condition subsequent to surgery were death, progression of
disease, disease static, partial response, complete response and no disease and the
explanatory variables were effect of (clinical) stage, age and primary treatment
(surgery). Briefly, the authors stated that the adjacent category logistic model and
the baseline category models partition an ordinal response into 2 adjacent pairs
with the adjacent category logistic model remaining invariant to changes in the
grouping of the categories in the response variable. Thus, based on the
continuation framework, the authors fitted a binary logistic, a binary logistic
normal and a binary logistic non-parametric model and found that a deviance of
1803.59, 1800.77 and 1794.73 respectively were attained by the 3 models. The
binary logistic non-parametric model was found to be most appropriate as it
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accommodated the irreversibly of the ordinal response categories.
Conclusion
Following the literature, predictive modeling can enable predictive factors and
prognostics to be utilized for accurate prescription of treatment to patients with
chronic diseases. This study aims to utilize the available data to identify key
predictive variables that will allow for the comparison of 3 regression models for
ordinal responses for the prediction of the surgical stage of HIV infected and





The determination of the FIGO clinical stage of cervical cancer usually starts with
a physical examination of the patient and is further supported by the availability
of the pathological result of the collected cervical tissue. A review of the literature
clearly shows that the clinical and laboratory parameters taken from women with
confirmed diagnosis of cervical cancer are key to determining the surgical stage of
women surgically treated for cervical cancer. This chapter aims to discuss the key
predictive variables that can be utilized to predict the surgical stage of women with
cervical cancer following surgical treatment and thus, develop, validate and compare
the odds ratio of 3 regression models for ordinal responses. The parameters of each
model were interpreted and the implication of each model evaluated on decision-
making for the candidacy of a patient to undergo surgical treatment for cervical
cancer. The details of the methods used are discussed and explained in this chapter.
3.2 Methods
Upon the study’s approval, we adopted a cross-sectional design which utilized the
retrospectively maintained database to identify all the women with International
FIGO stage 0 − IV B cervical cancer managed by the Oncology department as
outpatients at the MTRH’s CCCDC from January 2014 to December 2018.
Staging occurred according to the guidelines of the FIGO system; these did not
change during the inclusion period.
The 3 regression models for ordinal responses that were developed, validated and
compared were the Continuation Ratio model, the Polytomous (Multinomial)
Logistic model and the Adjacent-Category Logistic model. The primary endpoint
in this study was to build, validate and compare the odds ratio of 3 regression
models for ordinal responses and establish which model best estimates and
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predicts the surgical stage after surgical treatment of cervical cancer. The model of
choice should enable us to answer this question:
“Among the 3 regression models for ordinal responses, which model best estimates
and predicts the surgical stage prior to surgical treatment of cervical cancer?”
“In order to gain a better insight into the possibility of predicting a patient’s
surgical stage prior to surgery based on the clinical stage and key explanatory
variables, the R Studio statistical software was used to perform data analysis and
construct the regression models. We carried out an inferential approach and a
predictive approach. The inferential approach involved utilizing the original
cervical cancer data of 75 women as the train data and simulating the validation
(test) set of 10000 women with similar characteristics to the original data of 75
women. The predictive approach utilized the simulated data of 10000 women by
partitioning 80% into the train set and 20% into the validation set. We were able
to simulate the random sample of 10000 women with a weighted sampling scheme
using the sample() function in R studio.
Descriptive statistics was carried out to get the holistic view of the characteristics
of the women who sought treatment for cervical cancer at the Oncology
department at the MTRH’s Chandaria Cancer and Chronic Diseases Center.
Out of the 690 patients keyed into the cervical cancer database, only 75 were
found to be eligible to be utilized in this study. The information from these
patients was utilized to simulate a dataframe of 10000 patients with similar
characteristics to the 75 patients. We were able to generate a random sample with
a weighted sampling scheme by utilizing the sample() function in R
studio.Proportions were estimated for each of the 75 women and provided for the
weighted sampling. The response variable and the statistically significant
predictors were considered during the simulation.We carried out an inferential and
predictive approach which enabled the use of the original data and simulated data
respectively. For the inferential approach, the original data was utilized as the
train set in the development of the model and data simulated using the sample()
function utilized as the validation set. For the predictive approach, data was
simulated using the sample() function from the original data and the simulated
data partitioned into the train and validation sets.
3.3 Regression models for Ordinal responses
Regression analysis investigates the influence of multiple predictors or independent
variables on a dependent variable or outcome. In regression, an inferential
approach draws conclusions from estimates and tests performed whereas a
predictive approach tends to focus on past behaviors to enable better prediction of
future outcomes.
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The most commonly used model for the analysis of ordinal data is the
Proportional or Cumulative Odds model which follows the assumption of
proportional odds. The assumption of proportional odds in ordinal regression is
that the effects of any explanatory variables are consistent or proportional across
the different categories. Howbeit, Williams (2016) reports in his journal that the
observed relationship between the predictors and the response variables are greatly
misleading when the Cumulative Odds model assumptions is violated.
3.3.1 The Continuation Ratio Model
As a result of higher preference being given to the Cumulative Odds model for
the analysis of ordinal data, Liu (2010) asserts that the Continuation Ratio model
seems to be overlooked. Dolgun and Saracbasi (2014) states that this particular
model is best suited in situations where the individual categories of the outcome
variable are of intrinsic interest and are not arbitrary groupings of an underlying
continuous variable. The CR model is applied whenever the focus of a study is on
a particular category rather than at or below that category since a patient has to
pass through a lower category before achieving a higher category. In this study,
the ordinal categories for the CR model are successive stages of advancement in
disease. According to Liu (2010), the CR model estimates the conditional probability
P (Y > j|Y ≥ j) of being beyond a category Y > j given that patient has achieved
that particular category Y = j.
According to Allison, equation 3.1 shows the CR model as stated by Liu (2010),
given a set of predictors:
P (Y > j|Y ≥ j) = ln[P (Y≥j|x1,x2,...,xp)
P (Y=j|x1,x2,...,xp ] = αj + βpX
′
p (3.1)
where j = 1, 2, ..., j − 1 are the cut-points, β1, β2, ..., βp are the logit coefficients.
Also, the CR model estimates the odds of being in a particular category j
relative to being in that category or beyond.
Equation 3.2 shows the CR model as stated by Liu (2010)
whereP (Y = j|x1, x2, ..., xp) is the conditional probability of being in category j:
ln[P (Y=j|x1,x2,...,xp)
P (Y≥j|x1,x2,...,xp ] = αj + (−βpX
′
p) (3.2)
where j = 1, 2, ..., j − 1 are the cut-points, β1, β2, ..., βp are the logit coefficients.
Consequently, the CR model estimates the probability of a response falling into a
certain category (yi) given that the person has been in that category or beyond.
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3.3.2 Polytomous (Multinomial) Logistic Regression Model
The Pennsylvania State University expounds that binary logistic regression where
r = 2 categories can be broadened to manage Y responses that are polytomous
with r > 2 categories. This multi-category or polytomous responses can form a set
of r(r − 1)/2 logits or odds with only r − 1 being non-redundant logits. The
Polytomous logistic model is developed to predict the probabilities of the different
possible outcomes of a categorical non-ordered response variable , given a set of
predictor variables.
In a report by Starkweather and Moske (2011), the poytomous logistic regression
model uses the maximum likelihood estimation to evaluate the probability of
categorical membership. The author further states that the model’s appeal is the
non-assumption of normality, linearity and homoscedasticity, does not necessitate
careful sample size consideration and examination of the outlying cases.
Nonetheless, Starkweather and Moske (2011) insist that initial data analysis ought
to be thorough with meticulous univariate, bivariate and multivariate evaluation.
Moreover, multicollinearity among the independent variables should be evaluated
and multivariate diagnostics utilized to assess the multivariate outliers and the
exclusion of significant outliers. As stated by Starkweather and Moske (2011), the
Polytomous Logistic regression model should satisfy these assumptions to give
valid results:
1. Independence among the dependent response categories whereby membership
in one category is not related to membership of another category.
2. Non-perfect separation. In order to avoid the estimation of unrealistic
coefficients and great exaggeration of the effect size, the categories of the
response variable are not perfectly separated by the predictors.
Grace-Martin (2019) describes the response variable in polytomous logistic
regression as dummy coded into multiple 1 or 0 variables. If there are M
categories, then there will be M − 1 dummy variables meaning all but one
category has its own dummy variable. She further expounds that each category’s
dummy variable has a value of 1 for its category and 0 for all the remaining
categories. Notably, one category is considered as the reference category uniquely
identified by all the other variables as 0 thus it does not need its own dummy
variable. A separate binary regression model is estimated for each dummy variable
resulting in M − 1 binary regression models. The individual models each with its
own intercept and regression coefficients will estimate the effect of the predictors
on the probability of success in that specific category in comparison to the
reference category.
According to Rodŕıguez (2019b), consider models where the probabilities Yij
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depend on a vector xi of covariates associated with the ith category. In addition,
the maximum likelihood estimation of the parameters proceeds by maximization of
the multinomial likelihood with the probabilities Yij viewed as functions of αj and
βj parameters in equation 3.3.
Equation 3.3 shows the polytomous logit model as described by Rodŕıguez




= αj + x′iβj (3.3)
Similarly, Rodŕıguez (2019b) states that the Polytomous Logistic regression model
can estimate the original probabilities by adopting the convention that ηij = 0.
Equation 3.4 shows the polytomous logit model as described by Rodŕıguez (2019b)





where βj is a vector of regression coefficients for j = 1, 2, ..., j − 1 and αj is a
constant which brings about the assumption that the model matrix X does not
include a column of ones.
However, some of the checks that need to be done prior to carrying out a multinomial
logistic regression analysis as stated by Sharma (2019):
1. The response variable must be nominal. However, for multinomial regression,
we need to run ordinal logistic regression.
2. The categorical predictor variables must be converted to dummy variables.
3. Multicollinearity must not be present.
4. A linear relationship must exist between the response variable and the
continuous predictor variables.
5. Outliers and high influential points in the data must not be included.
Using R Studio, the mlogit package was utilized as it contains the functions to carry
out the polytomous logistic regression analysis. The assumption of independence was
tested by the Hausman-McFadden test. Starkweather and Moske (2011) explains
that the t test determines if each coefficient is significantly different from zero and
the Pseudo R2 (McFadden R2) is a measure of the size effect with the likelihood
ratio test being the alternative test of goodness of fit.
In studies related to cervical cancer, polytomous models were utilized by Lee et al.
(2015) to determine the odds of developing CIN 1 and CIN 2+ relative to women
with negative Papanicolaou smear results. The authors developed and validated 4
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cumulative risk score (CRS) schemes to improve Papanicolaou smear screening for
women at high risk with high DNA load of high-risk HPV being the main predictor
for CIN 1 and CIN 2 among other predictors. They determined that a simple CRS
scheme that integrated HR-HPV testing and verified risk factors could effectively
improve the identification of women at high risk of developing CIN2+. Lee et al.
(2015) established that the greatest accuracy of cervical lesion was noted in the CRS
schemes that included HPV testing.
3.3.3 The Adjacent-Category Logistic Model
In their article, Meisner et al. (2018) states that the set of logits generated by this
model is analogous to the set of logits generated by the Polytomous model with
the exception of the assuming a common β. The authors further report that this
model takes advantage of the the ordinal outcome to attain parsimony and is more
natural when interest lies in describing the effect of the predictor in terms of the
odds in relation to particular outcome levels. Moreover, this model does not include
cumulative probabilities thus an Adjacent-Category logistic model with separate
effects (the potential crossing of the cumulative probability curves, which violates
the ordering of the cumulative probabilities) is not a problem when utilizing this
model.
Dolgun and Saracbasi (2014) states that this particular model is often utilized due to
its close connection to log-linear models. Equation 3.5 as described by Ananth and
Kleinbaum (1997) shows that the adjacent-category logistic model involves modeling
the ratio of the two probabilities P (Y = yj) and P (Y = yj+1), j = 1, 2, ..., k.
log[
P (Y=yj |x)
P (Y=yj+1|x) ] = αj − x
′βj, j = 1, 2, ..., k (3.5)
Here, αk = 0 and βk = 0. According to Ananth and Kleinbaum (1997), β1
corresponds to the regression coefficient for the log-odds of Y = y1 relative to
Y = y2, β2 corresponds to the regression coefficient for the log-odds of Y = y2
relative to Y = y3, and so on with (k − 1) intercept parameters αj. Upon
exponentiating the regression coefficient βl for the lth covariate xl, we will obtain
the odds ratio of comparing Y = yj versus Y = yj+1 for a unit increase in xl.
3.4 Procedure
The research design for this study was cross-sectional. The data for the study was
retrospectively retrieved from the gynecological cervical cancer database. The data
had been collected previously and was parallel to the patients’ record files. The
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women who attend the gynecology clinic usually return for follow ups weekly,
monthly and after 3 months. The gynecologists use files to record patient
information at every visit and research assistants key in the recorded data into an
MS access database at the close of the clinic sessions.
690 women with complete records sought treatment at the oncology clinic with
only 75 women found to be eligible and their data utilized in the building of the
predictive models. Moreover, data was simulated to test the performance of the
developed models as the original data of 75 women was small to allow for
partitioning. The independent variables in this study were age at first contact with
the oncology team ranging from approximately 22 − 81, parity of at least 2 live
births per woman, international FIGO clinical stage which was dichotomized to
clinical stages 1 and 2, HIV status of patient limited to either being HIV positive
or HIV negative, vaginal involvement, parametrial involvement, marital status,
weight of patient, smoking status, contraceptive use, method of cancer detection,
biopsy pathology result, type of surgery done, symptoms which were either
bleeding, vaginal discharge or lower abdominal pain, location of the cervical cancer
tumour, grade of the tumour, the duration of the symptoms prior to diagnosis with
the options being < 1 month, < 6 months, < 1 year, > 1 year and not stated with
the dependent variable being surgical stage with the 3 categories being surgical
stages 0, 1 and 2.
Figure 3.1 show a flowchart displaying the surgical treatments that were availed
and the surgical stage outcomes.
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Figure 3.1: The surgical treatments availed and the surgical stage outcomes
Figure 3.2 is a flowchart displaying the surgical stage outcomes based on the
colposcopic biopsy results.
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Flowchart displaying cervical biopsy outcomes and FIGO clinical stages 
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Figure 3.2: The colposcopic biopsy results and the surgical stage outcomes
3.4.1 Statistical tests
In this study, regression models were used to explore the relationship between the
response variable (surgical stage) and the explanatory variables. The data was
analyzed using R studio version 3.6.1. Chi-square tests and analysis of variance
tests were carried out for categorical and numerical variables. The ANOVA test
allowed us to examine the variation in the frequencies within each surgical stage
(the response variable). Three regression models for ordinal data were developed
and their predictive performance evaluated by comparing the odds ratios. These
models were adapted because the response variable was an ordered variable. The 3
models were the multinomial (polytomous) logistic model, the continuation-ratio
model and the adjacent-category logistic model for which the later 2 were
developed with and without the proportional odds assumption.
We utilized R command multinom (Package: nnet) to fit 2 multinomial log-linear
models via neural networks For the ACL model, we utilized the R vgam package
that fits vector generalized and linear additive models appropriate to build the 2
adjacent-category models and the continuation ratio models both with and
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without proportional odds. We focused on the AIC goodness of fit statistic and
the log likelihood ratios to compare the models. The response variable was coded
as 0 for surgical stage 0, 1 for surgical stage 1 and 2 for surgical stage 2.
In their book, Meloun and Militky (2011) discussed the inferential tests for logistic
regression being the tests of models and the tests of individual predictors. The
author expounds that statistical inference is based on certain properties of
maximum-likelihood estimators and on likelihood ratio tests. In our study, we have
made comparisons between the null, univariate and multivariate models for the 3
regression models for ordinal responses. Among the several tests available, we
utilized the likelihood ratio test and the deviance. The likelihood ratio test is the
overall measure of how well the model fits and as stated by Meloun and Militky
(2011), is similar to the residual or the error sum of squares value for multiple
regression. The likelihood ratio test is the −2 times the log of the likelihood value
(−2LL or −2 log likelihood) with a well-fitting model having a small value with
the minimum value being 0 (−2LL =0). We can compare the likelihood value
between equations whereby the difference represents the change in predictive fit.
When the sample size is small or medium, Meloun and Militky (2011) reports that
the likelihood ratio test is more accurate compared to the Wald test as shown in
various simulation studies. Equation 3.6 defines the likelihood ratio test:
LR = −2[Lsubset − Lfull] = −2[ln(LsubsetLfull )] (3.6)
According to Meloun and Militky (2011), the likelihood ratio test is referred to as
the Deviance when the full model in the likelihood ratio test is the saturated model
(includes all possible terms including interactions). A saturated model allows for
the predicted values from the model to be equal to the original data. In generalized
linear models, the deviance statistic measures the deviance of the fitted GLM with
respect to a saturated model for E[Y |X1 = x1, . . . , Xp = xp]. A saturated model ,
also known as a perfect model is whereby the fitted responses (Ŷi) are the same as
the observed responses (Yi). Below is an example of a saturated model in logistic
regression:
P̂[Y = 1|X1 = Xi1, . . . , Xk = Xip] = Yi, i = 1, . . . , n.
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Additionally, the graphical representation 2.3 shows the saturated model and a
fitted logistic regression model.
Figure 3.3: Graphical representation of logistic regression versus a saturated model
and a null model
Portugués (2020) defines deviance as the difference of the log-likelihood between the
fitted model `(β̂) and the saturated model, `s. When the µi is substituted by Yi in
equation ?? and θi = g(Yi) if the canonical link function is utilized.
Equation ?? defines the log likelihood function and the deviance are shown as






The author further expounds that the log likelihood for the fitted model `(β̂) is
always smaller than that of the saturated model `s. The deviance is equal to or larger
than zero. A model that has a perfect fit will have a deviance of zero. Moreover,
the deviance statistic is a generalization of the residual sum of squares of the linear
model.
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Figure 3.4: Graphical representation of logistic regression versus a saturated model
and a null model
Figure 2.3 supports that the null deviance is the deviance of the worst model.
The null model is considered the chosen benchmark for evaluating the scale of the
deviance. The deviance and null deviance compare the models’ improvement when
predictors X1, . . . , Xp are added and measure the percentage of explained deviance.












In a similar manner, he states that the R2 statistic is a measure or proportion of how
well the model fits and a generalization of the determination coefficient for linear
regression. D = D0 and R
2 = 0 indicate that the predictors did not improve the
regression and D = 0 and R2 = 1 indicate a model that fits perfectly.
The data was analyzed using R studio version 3.6.1. Chi-square tests and analysis of
variance tests were carried out for categorical and numerical variables. The ANOVA
test allowed us to examine the variation in the frequencies within each surgical stage
(the response variable). Three regression models for ordinal data were developed
and their predictive performance evaluated by comparing the odds ratios. These
models were adapted because the response variable was an ordered variable. The 3
models which were developed with and without the proportional odds assumption
were the multinomial (polytomous)logistic model, the continuation-ratio model and
the adjacent-category logistic model. We utilized R command multinom (Package:
nnet) to fit 2 multinomial log-linear models via neural networks with and without
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the proportional odds assumption. For the ACL model, we utilized the R vgam
package that fits vector generalized and linear additive models appropriate to build
the 2 adjacent-category models and the continuation ratio models both with and
without proportional odds. We focused on the AIC goodness of fit statistic and the
log likelihood ratios to compare the models. The response variable was coded as 0




4.1 Subjects of the study
In total, 87 women diagnosed with cervical cancer were found to fit the eligibility
criteria between January 2014 and December 2018. We excluded women with
unknown HIV status and incomplete follow up data within the stipulated period.
Of these women, 61.4% and 18.0% were HIV infected and HIV uninfected women
respectively. Based on the women who were on treatment to the end of the
stipulated time period, a total of 311 and 312 women were clinically staged
between stage 0 − 4B cervical cancer at baseline and at end of the time period
respectively.
Table 1 below shows the characteristics of the women who underwent surgical
treatment and whose records were found to be complete. At this particular time
period,the characteristics of the women who were followed up from the start to the
end of this period were analyzed.
Among the women who were surgically treated for cervical cancer, 87 women were
surgically staged and considered eligible to participate in this study. The
distribution of the surgical stage, which is the response variable was higher for
surgical stage 0(66.67%) compared to surgical stage 1(20.00%) and surgical stage
2(13.33%). There was none classified under surgical stage 3 and 2 women classified
under surgical stage 4 were excluded to minimize bias of the results. The mean
womens’ age and the median age at diagnosis was 46.61 and 46.00 and the
frequently occurring clinical stage was 1B2 followed by 1B1. The predominant
histologic type was squamous cell carcinoma at 63(86.3%). The patients diagnosed
and listed as being with adenocarcinoma, adeno-squamous carcinoma and other
were dropped from the analysis. The surgical treatments offered were radical
hysterectomy, cone biopsy and abandoned radical hysterectomy with 1 unspecified.
The type of surgical treatment was not statistically associated to the surgical stage
outcomes. The mean overall weight was 64.76 kilograms (range: 0.00 − 163.00).
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The marital status was classified as either single or married. The single patients
comprised of the singles, widows, divorced and those who did not state their
marital status. The majority of the women were married (76.8%) with the rest
being single (23.2%) and the mean number of delivered pregnancies was
approximately 5. Among the types of contraceptive methods being utilized, the
depo provera method seems to be highly preferred by the women in this study.
The international FIGO clinical stages were merged into clinical stages 1 and 2
and found to be 78.67% and 21.33% respectively with the clinical stage stated as
‘others’ being dropped. It became quite clear that on categorizing the FIGO
clinical stages as 1 and 2 only, it was found to be statistically significant with a
p-value of < 0.001. The major method of cervical cancer detection was based on
patient symptoms with 44 (61.1%) women followed by 20 (27.8%) women who
were diagnosed during cervical cancer screening testing . The method of detection
was not statistically significantly associated with the surgical stage outcomes.
Majority of the patients were non-smokers 73(97.3%) and was not statistically
associated with the surgical stage outcomes. The location of the tumour was not
statistically associated with the surgical stage outcomes with 48.5% of women
having the tumour on both the endocervical and exocervical canal.
The predictors that were found to be statistically significant to the surgical stage
were the FIGO clinical stage (p-value=< 0.001), the vaginal involvement
(p-value=< 0.001), the parametrial involvement (p-value=0.008), symptomatic
vaginal discharge (p-value=0.029) and symptomatic lower abdominal pain









Parity     0.615 
   N-Miss 4 1 0 5  































Clinical Stage     < 
0.001 
   1 43 (86.0%) 13 (86.7%) 3 (30.0%) 59 (78.7%)  
   2 7 (14.0%) 2 (13.3%) 7 (70.0%) 16 (21.3%)  
Age at first clinical 
contact 
    0.595 
   N-Miss 3 0 0 3  































HIV Status     0.509 
   Negative 42 (84.0%) 13 (86.7%) 7 (70.0%) 62 (82.7%)  
   Positive 8 (16.0%) 2 (13.3%) 3 (30.0%) 13 (17.3%)  
Vaginal Involvement     < 
0.001 
   No 48 (96.0%) 14 (93.3%) 5 (50.0%) 67 (89.3%)  
   Yes 2 (4.0%) 1 (6.7%) 5 (50.0%) 8 (10.7%)  
Parametrial 
Involvement 
    0.008 
   No 49 (98.0%) 13 (86.7%) 7 (70.0%) 69 (92.0%)  
   Yes 1 (2.0%) 2 (13.3%) 3 (30.0%) 6 (8.0%)  
Table 1: Descriptive statistics for the predictor variables with a chi-square test and an anova test
carried out for each categorical and numerical predictor respectively.
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Marital Status     0.757 
   N-Miss 5 0 0 5  
   Married 37 (82.2%) 11 (73.3%) 8 (80.0%) 56 (80.0%)  
   Single 8 (17.8%) 4 (26.7%) 2 (20.0%) 14 (20.0%)  
Weight     0.690 































Smoker     0.526 
   No 49 (98.0%) 14 (93.3%) 10 (100.0%) 73 (97.3%)  
   Yes 1 (2.0%) 1 (6.7%) 0 (0.0%) 2 (2.7%)  
Contraception: None     0.725 
   No 36 (72.0%) 11 (73.3%) 6 (60.0%) 53 (70.7%)  
   Yes 14 (28.0%) 4 (26.7%) 4 (40.0%) 22 (29.3%)  
Contraception: 
Condoms 
     
   No 50 (100.0%) 15 (100.0%) 10 (100.0%) 75 (100.0%)  
   Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
Contraception: 
Intrauterine.Device 
    0.274 
   No 45 (90.0%) 12 (80.0%) 10 (100.0%) 67 (89.3%)  
   Yes 5 (10.0%) 3 (20.0%) 0 (0.0%) 8 (10.7%)  
Contraception: 
Oral Pill 
    0.122 
   No 46 (92.0%) 12 (80.0%) 7 (70.0%) 65 (86.7%)  
   Yes 4 (8.0%) 3 (20.0%) 3 (30.0%) 10 (13.3%)  
Contraception: 
Depo Provera 
    0.838 
   No 37 (74.0%) 12 (80.0%) 7 (70.0%) 56 (74.7%)  





    0.146 
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Method of Cancer 
Detection 
   N-Miss 1 1 1 3  
   Incidental 2 (4.1%) 1 (7.1%) 0 (0.0%) 3 (4.2%)  
   Screening 18 (36.7%) 2 (14.3%) 0 (0.0%) 20 (27.8%)  
   Symptoms 25 (51.0%) 10 (71.4%) 9 (100.0%) 44 (61.1%)  
   Via 4 (8.2%) 1 (7.1%) 0 (0.0%) 5 (6.9%)  
Cervical biopsy 
Pathology result 
    0.245 
   N-Miss 2 0 0 2  
   Adeno Carcinoma 1 (2.1%) 2 (13.3%) 0 (0.0%) 3 (4.1%)  
   Adeno Squamous 1 (2.1%) 0 (0.0%) 0 (0.0%) 1 (1.4%)  
   Other 6 (12.5%) 0 (0.0%) 0 (0.0%) 6 (8.2%)  
   Squamous Cell 40 (83.3%) 13 (86.7%) 10 (100.0%) 63 (86.3%)  
Surgery Done     0.940 
   N-Miss 3 0 0 3  
   Abandoned Radical 
Hysterectomy 
2 (4.3%) 1 (6.7%) 0 (0.0%) 3 (4.2%)  
   Cone Biopsy 1 (2.1%) 0 (0.0%) 0 (0.0%) 1 (1.4%)  
   Other 1 (2.1%) 0 (0.0%) 0 (0.0%) 1 (1.4%)  
   Radical Hysterectomy 43 (91.5%) 14 (93.3%) 10 (100.0%) 67 (93.1%)  
Symptom: Bleeding     0.169 
   No 21 (42.0%) 3 (20.0%) 2 (20.0%) 26 (34.7%)  
   Yes 29 (58.0%) 12 (80.0%) 8 (80.0%) 49 (65.3%)  
Symptom: Discharge     0.029 
   No 34 (68.0%) 5 (33.3%) 4 (40.0%) 43 (57.3%)  
   Yes 16 (32.0%) 10 (66.7%) 6 (60.0%) 32 (42.7%)  
Symptom: Pain     0.048 
   No 34 (68.0%) 5 (33.3%) 5 (50.0%) 44 (58.7%)  
   Yes 16 (32.0%) 10 (66.7%) 5 (50.0%) 31 (41.3%)  
Tumour Location     0.347 
   N-Miss 31 6 5 42  
   Both 7 (36.8%) 6 (66.7%) 3 (60.0%) 16 (48.5%)  
   Endo-cervix 6 (31.6%) 0 (0.0%) 0 (0.0%) 6 (18.2%)  
   Exo-cervix 5 (26.3%) 3 (33.3%) 2 (40.0%) 10 (30.3%)  
   None 1 (5.3%) 0 (0.0%) 0 (0.0%) 1 (3.0%)  
Grade     0.576 
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   N-Miss 2 0 0 2  
   Grade 1 5 (10.4%) 0 (0.0%) 0 (0.0%) 5 (6.8%)  
   Grade 2 12 (25.0%) 4 (26.7%) 2 (20.0%) 18 (24.7%)  
   Grade 3 11 (22.9%) 4 (26.7%) 2 (20.0%) 17 (23.3%)  
   Grade Not Stated 16 (33.3%) 7 (46.7%) 6 (60.0%) 29 (39.7%)  
   N/A 4 (8.3%) 0 (0.0%) 0 (0.0%) 4 (5.5%)  
Symptoms Duration     0.322 
   N-Miss 23 3 2 28  
   < 1 Months 2 (7.4%) 0 (0.0%) 0 (0.0%) 2 (4.3%)  
   < 1 Year 3 (11.1%) 1 (8.3%) 3 (37.5%) 7 (14.9%)  
   < 6 Months 8 (29.6%) 2 (16.7%) 3 (37.5%) 13 (27.7%)  
   > 1 Year 1 (3.7%) 2 (16.7%) 1 (12.5%) 4 (8.5%)  
   N/A 2 (7.4%) 0 (0.0%) 0 (0.0%) 2 (4.3%)  
   Not Stated 11 (40.7%) 7 (58.3%) 1 (12.5%) 19 (40.4%)  
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Table 4.1 lists the actual counts for the original (train) and simulation (test) data
sets respectively utilized in the inferential analysis.
Category Actual (train) dataset Simulated (test) dataset
Surgical stage 0 50 6676
Surgical stage 1 15 2019
Surgical stage 2 10 1305
Table 4.1: Counts for patients in each surgical stage
4.2 Regression Analysis based on the Inferential
approach
4.2.1 Polytomous (Multinomial) Logistic Regression Model
During the analysis, the reference category for the multinomial (polytomous)
model was surgical stage 0. The 3 models fitted were the null model, univariate
model and the multivariate model. We determined the presence of a relationship
between the response variable and a combination of predictor variables by
performing a likelihood ratio test. The results showed that the statistical
significance of the probability of the model likelihood ratio (13.26) was 0.00132
indicating that there was a significant difference between the null (no predictors)
and the univariate ML model (FIGO clinical stage only). Moreover, the
probability of the model likelihood ratio (18.15) was 0.02013 showing a significant
difference between the univariate and the multivariate ML models.
The ML model generalizes logistic regression to multiple outcome categories and
thus, predicts the probabilities of the different possible outcomes of the outcomes
given a set of predictor variables. The model attempts to explain the relative effect
of the predictor variables on the surgical stage outcomes. Table 4.2 shows the null
MLR model. The aim of the null model was to better understand the marginal
distribution of the response variable in the absence of predictors.
Table 4.3 shows the fitted univariate MLR model with the international FIGO
clinical stage as the sole predictor variable. The output shows that the log odds of
being in surgical stage 1 compared to surgical stage 0 (reference category)
decreased by 0.06 if moving from clinical stage 1 to clinical stage 2 and the log
odds of being in surgical stage 2 compared to surgical stage 0(reference category)
increased by 2.66 if moving from clinical stage 1 to clinical stage 2. The intercepts
show the log odds for surgical stage 0 (reference category).
Table 4.4 shows the summary for a multivariate model built with the inclusion of
the 5 statistically significant predictors. The first model compares surgical stage 1
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to surgical stage 0 (reference category). We found that all the predictor variables
were statistically insignificant and not associated to the surgical stage outcomes.
The second model compares surgical stage 2 to surgical stage 0 where we found
that only the FIGO clinical stage had a significant effect based on a p-value of
0.02297. The other 4 predictor variables were not significant to the surgical stage
outcomes.
The log odds of being in surgical stage 1 compared to the surgical stage 0 will
increase by 0.007 if moving from clinical stage 1 to clinical stage 2 and the log
odds of being in surgical stage 2 compared to surgical stage 0 will increase by
2.401 if moving from clinical stage 1 to clinical stage 2. Thus, FIGO clinical stage
exhibited positive regression coefficients and likelihood of increment with the
higher categories of surgical stage. The log odds of being in surgical stage 1
compared to surgical stage 0 decreased by 0.359 if there was vaginal involvement
observed during diagnosis and the log odds of being in surgical stage 2 compared
to surgical stage 0 increased by 1.061 if there was vaginal involvement observed
during diagnosis. The log odds of being in surgical stage 1 compared to surgical
stage 0 increased by 1.509 and the log odds of being in surgical stage 2 compared
to surgical stage 0 increased by 2.911 if the parametrium region was affected by
the cervical cancer. The positive regression coefficients indicated that observed
parametrial involvement was likely to lead to a higher category of surgical stage.
The log odds of being in surgical stage 1 compared to surgical stage 0 increased by
1.261 and by 1.209 when a patient displayed symptomatic vaginal discharge and
lower abdominal pain respectively. The log odds of being in surgical stage 2
compared to surgical stage 0 increased by 0.934 and decreased by 0.155 when a
patient displayed symptomatic vaginal discharge and lower abdominal pain
respectively.
Coefficient Standard Errors z-statistic p-value
Surgical Stage 1
Intercept -1.204 0.294 -4.10 0.00004
Surgical Stage 2
Intercept -1.610 0.350 -4.65 0.00000
Table 4.2: Summary for a null ML model.
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Coefficient Standard Errors z-statistic p-value
Surgical Stage 1
Intercept -1.20 0.32 -3.78 0.00016
Clinical Stage 2 -0.06 0.86 -0.07 0.94757
Surgical Stage 2
Intercept -2.66 0.60 -4.46 0.00001
Clinical Stage 2 2.66 0.80 3.32 0.00089
Table 4.3: Summary for a univariate ML model built with the inclusion of the FIGO
clinical stage predictor.
Coefficient Standard Errors z-statistic p-value
Surgical Stage 1
Intercept -1.20 0.32 -3.78 0.00016
Clinical Stage 2 -0.06 0.86 -0.07 0.94757
Vaginal Involvement: Yes -0.359 1.623 -0.221 0.82509
Parametrial Involvement: Yes 1.509 1.354 1.114 0.26528
Symptoms Discharge: Yes 1.261 0.657 1.919 0.05498
Symptoms Pain: Yes 1.209 0.659 1.835 0.06651
Surgical Stage 2
Intercept -3.494 0.901 -3.878 0.00011
Clinical Stage 2 2.401 1.056 2.274 0.02297
Vaginal Involvement: Yes 1.061 1.183 0.897 0.36972
Parametrial Involvement: Yes 2.911 1.538 1.893 0.05836
Symptoms Discharge: Yes 0.934 0.910 1.026 0.30489
Symptoms Pain: Yes -0.155 0.975 -0.159 0.89367
Table 4.4: Summary for a multivariate ML model built with the inclusion of the 5
statistically significant predictors.
Plot 4.1 features an effects plot which displays the predicted values of the surgical
stage for given values of the predictor variables. The predicted value was obtained
by inserting the predictor values into the ML multivariate model. The plot shows
that there is a higher chances of being classified under surgical stage 0 for patients
with FIGO clinical stage 1 and reduced chances for patients with FIGO clinical stage
2. In contrast, it was clear that the chances of being classified under surgical stage
2 were higher for patients with FIGO clinical stage 2 compared to patients with
FIGO clinical stage 1. There was hardly any difference between the patients with
FIGO clinical stage 1 and 2 when it came to being classified under surgical stage
1. Clearly, this supports the regression coefficient estimates from the univariate and
multivariate ML models.
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Figure 4.1: An Effects plot
Table 4.5 displays the goodness of fit statistics for the 3 models. The full ML
model with the 5 statistically significant predictor variables had the lowest AIC
and residual deviance of 121.72 and 97.72 respectively with the highest log
likelihood ratio of −48.860. Thus, the multivariate multinomial logistic model was
a better fit for the cervical cancer data compared to the univariate and null
models.The presence of a relationship between the response variable and the
combination of predictor variables was determined by a likelihood ratio test. The
statistical significance of the probability of the model likelihood ratio (13.26) was
0.00132 shows that there was a significant difference between the null (no predictor
variables) and the univariate model (FIGO clinical stage predictor only) . Also, the
probability of the model likelihood ratio (18.15) was 0.02013 showing a significant
difference between the univariate and multivariate models for the ML model.
Deviance Log Likelihood AIC
Null ML model 115.87 -57.94 123.87
Univariate ML model 129.13 -64.56 133.13
Multivariate ML model 97.72 -48.86 121.72
Table 4.5: Goodness of fit statistics for the ML models
Equation 4.1 and 4.2 show the multivariate ML model for surgical stage 1 and
surgical stage 2 both compared to the surgical stage 0 (the reference category).
Based on the goodness-of-fit statistics, these 2 ML models were considered best in
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the classification of the surgical stage outcomes.
log[P (SS = 1|SS = 0)][= −1.200(0.320)− 0.060(0.860)clinicalstage−
0.359(1.623)V aginalinvolvement+ 1.509(1.354)
Parametrialinvolvement+ 1.261(0.657)
Symptom : Discharge+ 1.209(0.659)Symptom : Pain]
(4.1)
log[P (SS = 2|SS = 0][= −3.494(0.901) + 2.401(1.056)clinicalstage
+ 1.061(1.183)V aginalinvolvement+ 2.911(1.538)Parametrialinvolvement
+ 0.934(0.910)Symptom : Discharge− 0.155(0.975)Symptom : Pain]
(4.2)
Confusion matrices 4.6 and 4.7 derived for the train and validation set gave an
accuracy of 70%[95%CI : 59.02% − 80.62%] and
62.97%[95%CI : 62.01%− 63.92%]. With reference to table 4.8, the sensitivity for
surgical stage 0, 1 and 2 was 0.960, 0.0667 and 0.4000 for the train set and
0.926, 0.0521 and for 0.0223 for the validation set. The specificity for surgical stage
0, 1 and 2 was 0.280, 0.983 and 0.954 for the train set and 0.073, 0.974 and for
0.953 for the validation set.
Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 48 0 2
Surgical stage one 13 1 1
Surgical stage two 5 1 4
Table 4.6: Confusion matrix of the multivariate ML model based on the train set.
Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 45 39 172
Surgical stage one 90 68 320
Surgical stage two 1884 1198 6184





Surgical stage zero 0.9600 0.2800 0.6667
Surgical stage one 0.0667 0.9833 0.2000
Surgical stage two 0.4000 0.9539 0.1333
Validation set
Surgical stage zero 0.9263 0.0728 0.6676
Surgical stage one 0.0223 0.9736 0.2019
Surgical stage two 0.0521 0.9529 0.1305
Table 4.8: Sensitivity, specificity and Prevalance for the multivariate ML model
based on the train and validation set respectively.
With the best fit model being the multivariate ML model, the odds ratios were
extracted from the models. The odds ratios 4.9 extracted from the multivariate
multinomial logistic model which displayed the best fit model for the cervical
cancer data. The odds of being classified into surgical stage 1 over surgical stage 0
was 1.01 [CI: 0.13 − 7.61] higher for patients diagnosed with FIGO clinical stage 2
versus those diagnosed with FIGO clinical stage 1 while holding all other
predictors constant. Moreover, the odds of being classified into surgical stage 2
over surgical stage 0 was 11.03 CI:[1.39 − 87.36] times higher for patients
diagnosed with FIGO clinical stage 2 versus those diagnosed with FIGO clinical
stage 1 while holding all other predictors constant. The odds of being classified
into surgical stage 1 over surgical stage 0 was 0.70 CI:[0.13− 7.61] times lower and
in contrast,the odds of being in surgical stage 2 over surgical stage 0 was2.89 CI:
[0.28 − 29.35] times higher for patients with the vaginal region observed to be
affected by the cancer during diagnosis versus those without any vaginal
involvement while holding all other predictors constant. The odds of being
classified into surgical stage 1 over surgical stage 0 was 4.52 CI: [0.3− 64.28] times
higher and the odds of being classified into surgical stage 2 over surgical stage 0
was 18.38 CI: [0.9 − 374.72] times higher for patients with the parametrial region
affected by the cancer versus those without any parametrial involvement while
holding other predictors constant. The odds of being classified into surgical stage 1
over surgical stage 0 was 3.53 CI: [0.97− 12.78] times higher and the odds of being
classified into surgical stage 2 over surgical stage 0 was 2.54 CI: [0.43 − 15.13]
times higher for the patients with symptomatic vaginal discharge during diagnosis
versus those without the symptomatic vaginal discharge, holding all other
predictors constant. The odds of being classified into surgical stage 1 over surgical
stage 0 was 3.35 CI:[0.92 − 12.18] times higher and in contrast, the odds of being
into surgical stage 2 over surgical stage 0 was 0.86 CI:[0.13 − 5.79] times lower for
the patients with symptomatic lower abdominal pain versus those without any
pain, holding all other predictors constant.
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Intercept Clinical Stage 2 Vaginal Involvement Parametrial Involvement Symptoms Discharge Symptoms Pain
Surgical Stage 1
Coefficient -2.499 0.007 -0.359 1.509 1.261 1.209
Std Error 0.622 1.032 1.623 1.354 0.657 0.659
Z statistic -4.018 0.007 -0.221 1.114 1.919 1.835
p-value <0.01 0.9944 0.82509 0.26528 0.05498 0.06651
OR (95% CI) 0.08(0.02, 0.28) 1.01(0.13, 7.61) 0.07(0.03, 16.83) 4.52(0.32, 64.28) 3.53(0.97, 12.78) 3.35 (0.92, 12.18)
Surgical Stage 2
Coefficient -3.494 2.401 1.061 2.911 0.934 -0.155
Std Error 0.901 1.056 1.183 1.538 0.91 0.975
Z statistic -3.878 2.274 0.897 1.893 1.026 -0.159
p-value <0.001 0.02297 0.36972 0.05836 0.30489 0.87367
OR (95% CI) 0.03(0.01,0.18) 11.03(1.39,87.36) 2.89(0.28,29.35) 18.38(0.9,374.72) 2.54(0.43,15.13) 0.86(0.13, 5.79)
Table 4.9: The table of the odds ratios extracted from the multivariate ML model
which displayed the best fit model for the cervical cancer data.
4.2.2 Continuation Ratio Model
When the focus is on a particular category given that a patient must pass through
a lower surgical stage category before achieving a higher category, the continuation
ratio model is considered a more appropriate choice. The proportional odds
assumption was tested by fitting this particular model with and without the
proportional odds assumption.
The tables below show the output for the CR null, univariate and multivariate
models with and without proportional odds respectively. The univariate CR model
with and without proportional odds output considered the FIGO clinical stage as
the only predictor. Clearly, the CR univariate model with proportional odds
showed that the FIGO clinical stage had a significant effect on the surgical stage
response with a p-value of 0.000892 when the regression coefficient was common.
The estimated log regression coefficient for the FIGO clinical stage ,
β = 1.649(0.496), z = 3.322 and p < 0.05 showed that the FIGO clinical stage
upon diagnosis had a positive effect on the surgical stage responses. The CR
model without proportional odds gave separate effects. The FIGO clinical stage
predictor variable was found to be statistically significant. For having a surgical
stage outcome greater than surgical stage 1 relative to being in surgical stage 1,
the estimated log regression coefficient for the FIGO clinical stage was
β = 1.240(0.583), z-value= 2.127 and a p-value of 0.0334 indicating that the FIGO
clinical stage had a significant positive effect on the surgical stage 1 responses. In
addition, having a surgical stage outcome greater than surgical stage 2 relative to
being in surgical stage 2, the estimated logit regression coefficient for FIGO clinical
stage was β = 2.719(1.026), z-value=2.650 and a p-value of 0.00805 indicating that
the FIGO clinical stage had a significant positive effect on surgical stage 2
responses.
The multivariate CR model with and without proportional odds output with the 5
predictors that were found to be statistically significant were included.For the CR
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multivariate model with proportional odds, only the FIGO clinical stage estimated
log regression coefficient, β = 1.449(0.632), z-value=2.293 had a positive effect on
the surgical stage responses. In addition, a p-value of 0.02182 showed that the
FIGO clinical stage is a statistically significant predictor for having a surgical stage
outcome greater than surgical stage 1 relative to being in surgical stage 1 as well as
having a surgical stage outcome greater than surgical stage 2 relative to being in
surgical stage 2. The remaining 4 predictors that were not statistically significant
to the surgical stage responses were vaginal involvement, parametrial involvement,
symptomatic vaginal discharge and lower abdominal pain. For the CR multivariate
model without proportional odds, we got separate effects for the surgical stage
responses.For having a surgical stage outcome greater than surgical stage 1 relative
to being in surgical stage 1, the symptomatic vaginal discharge was found to have
a positive effect and was significant with an estimated logit coefficient
β = 1.103(0.568), z-value=1.943 and a p-value of 0.052. The estimated logit
coefficients for FIGO clinical stage, vaginal involvement,parametrial involvement
and symptomatic lower abdominal pain were not statistically significant and had
no effect . Also, it was clear that for having a surgical stage outcome greater than
surgical stage 2 relative to being in surgical stage 2, the FIGO clinical stage had a
positive effect and was statistically significant with an estimated logit regression
coefficient of β = 3.833(1.817), z-value=2.109 and p-value of 0.0349. The estimated
logit regression coefficients for vaginal involvement,parametrial involvement,
symptomatic vaginal discharge and symptomatic lower abdominal pain were not
statistically significant and had no effect.
Coefficient Standard Errors z-statistic p-value
CR Model with Proportional Odds
Intercept1 -0.693 0.245 -2.830 < 0.00466
Intercept2 -0.405 0.40892 -0.993 < 0.32062
CR Model without Proportional Odds
Intercept1 -0.693 0.245 -2.830 < 0.00466
Intercept2 -0.405 0.408 -0.993 0.32062
Table 4.10: The Summary for a CR null model.
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Coefficient Standard Errors z-statistic p-value
CR Model with Proportional Odds
Intercept1 -1.092 0.288 -3.790 < 0.00015
Intercept2 -1.042 0.492 -2.115 < 0.03443
Clinical Stage 2 1.649 0.496 3.322 0.00089
CR Model without Proportional Odds
Intercept1 -0.989 0.293 -3.376 < 0.00074
Intercept2 -1.466 0.641 -2.289 0.02206
Clinical Stage 1 1.240 0.583 2.127 0.03339
Clinical Stage 2 2.719 1.026 2.650 0.00806
Table 4.11: The Summary for a CR univariate model with the inclusion of the FIGO
clinical stage predictor.
Coefficient Standard Errors z-statistic p-value
CR Model with Proportional Odds
Intercept1 -1.773 0.441 -4.021 < 0.01
Intercept2 -2.254 0.698 -3.229 < 0.01
Clinical Stage 2 1.449 0.632 2.293 0.022
Vaginal Involvement: Yes 0.982 0.868 1.131 0.258
Parametrial Involvement: Yes 1.61 0.882 1.825 0.068
Symptoms Discharge: Yes 0.717 0.498 1.438 0.1504
Symptoms Pain: Yes 0.382 0.507 0.754 0.4508
CR Model without Proportional Odds
Intercept1 -2.05 0.512 -4.001 < 0.01
Intercept2 -1.195 1.239 -0.965 0.335
Clinical Stage 1 1.001 0.787 1.271 0.204
Clinical Stage 2 3.833 1.817 2.109 0.035
Vaginal Involvement: Yes1 0.736 1.161 0.634 0.526
Vaginal Involvement: Yes2 1.584 1.699 0.933 0.351
Parametrial Involvement: Yes1 1.829 1.223 1.495 0.131
Parametrial Involvement: Yes2 3.220 1.918 1.679 0.093
Symptoms Discharge: Yes1 1.103 0.568 1.943 0.052
Symptoms Discharge: Yes2 -1.412 1.542 -0.916 0.360
Symptoms Pain: Yes1 0.823 0.577 1.427 0.154
Symptoms Pain: Yes2 -0.832 1.515 -0.209 0.227
Table 4.12: The Summary for a CR multivariate model with the inclusion of the 5
predictors for Surgical Stage 1 and Stage 2.
Table 4.13 displays the goodness of fit statistics for the 3 models. An AIC of
118.899 shows that the multivariate CR model without proportional odds gave the
best fit for the cervical cancer data with further confirmation based on a residual
deviance and log likelihood ratio of 94.89 and −47.44 respectively. Moreover, the
VGAM likelihood ratio test was carried out for the 2 CR multivariate models and
a chi-square p-value of 0.08023 showed that the fit was not significantly different
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and thus, the multivariate CR model without proportional odds was found to be
adequate.
Deviance Log Likelihood AIC
Null CR model 129.13 -64.56 133.13
Univarite CR model 117.56 -58.78 123.56
Multivariate CR model 104.72 -52.36 118.72
Deviance Log Likelihood AIC
Null CR model 129.13 -64.56 133.13
Univariate CR model 115.87 -57.94 123.87
Multivariate CR model 94.89 -47.44 118.89
Table 4.13: Goodness of fit statistics for the CR models with and without
Proportional Odds respectively
Equation 4.3 and 4.4 show the multivariate CR model without proportional odds
assumptions for surgical stage 1 and surgical stage 2. Based on the goodness-of-fit
statistics, these 2 CR models without proportional odds were considered best in the
classification of the surgical stage outcomes.
log[P (SS = 1|SS ≥ 1)][= −2.050(0.512) + 1.001(0.787)clinicalstage+
0.736(1.161)V aginalinvolvement+ 1.829(1.223)
Parametrialinvolvement+ 1.103(0.568)
Symptom : Discharge+ 0.823(0.577)Symptom : Pain]
(4.3)
log[P (SS = 2|SS ≥ 2][= −1.1950(1.239) + 3.833(1.817)clinicalstage
+ 1.584(1.699)V aginalinvolvement+ 3.220(1.918)Parametrialinvolvement
− 1.412(1.542)Symptom : Discharge− 1.832(1.515)Symptom : Pain]
(4.4)
The 3 CR models with and without proportional odds were compared to determine
the model best fit for the cervical cancer data. The fitted multivariate CR model
with proportional odds had a misclassification rate of 29.33% and 37.74% whereas
the fitted multivariate CR model without proportional odds had a misclassification
rate of 30.67% and 39.09% when the train and validation data sets were utilized
respectively.
Confusion matrices 4.14 and 4.15 derived for the train and validation set from
the multivariate CR model without proportional odds gave an accuracy of
69.33%[95%CI : 57.62% − 79.47%] and 60.91%[95%CI : 59.95% − 61.87%]. With
reference to table 4.16, the sensitivity for surgical stage 0, 1 and 2 was 0.734,
0.333 and 0.500 for the train set and 0.668, 0.227 and 0.132 for the validation set.
The specificity for surgical stage 0, 1 and 2 was 0.727, 0.806 and 0.910 for the train
set and 0.338, 0.799 and for 0.870 for the validation set.
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Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 47 1 2
Surgical stage one 12 1 2
Surgical stage two 5 1 4
Table 4.14: Confusion matrix of the multivariate CR model without proportional
odds based on the train set.
Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 5883 329 464
Surgical stage one 1779 119 121
Surgical stage two 1140 76 89
Table 4.15: Confusion matrix for the multivariate CR model without proportional
odds based on the validation set
Sensitivity Specificity Prevalance
Train set
Surgical stage zero 0.9600 0.2800 0.6667
Surgical stage one 0.0667 0.9833 0.2000
Surgical stage two 0.4000 0.9539 0.1333
Validation set
Surgical stage zero 0.6684 0.3381 0.8802
Surgical stage one 0.2271 0.7995 0.0524
Surgical stage two 0.1320 0.8696 0.0674
Table 4.16: Sensitivity, Specificity and Prevalance for the multivariate CR model
without proportional odds based on the train and validation set respectively.
Table 4.17 shows the extracted odds ratios for the best fit model which was found
to be the CR model without proportional odds.
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Predictor variables Odds ratio CI: 2.5 % CI: 97.5 %
(Intercept):1 0.13 0.05 0.35
(Intercept):2 0.30 0.03 3.43
Clinical.Stage 2:1 2.72 0.58 12.72
Clinical.Stage 2:2 46.20 1.31 1627.54
Vaginal.Involvement Yes:1 2.09 0.21 20.30
Vaginal.Involvement Yes:2 4.88 0.17 136.11
Parametrial.Involvement Yes:1 6.23 0.57 68.45
Parametrial.Involvement Yes:2 25.02 0.58 1073.25
Symptoms...Discharge Yes:1 3.01 0.99 9.16
Symptoms...Discharge Yes:2 0.24 0.01 5.00
Symptoms...Pain Yes:1 2.28 0.74 7.06
Symptoms...Pain Yes:2 0.16 0.01 3.12
Table 4.17: Odds Ratios for the CR model without Proportional Odds
For the model 4.3 logit[P (SS = 1|SS ≥ 1] and model 4.4 logit[P (SS = 2|SS ≥ 2]
respectively, the odds of having an outcome greater than surgical stage 1 relative
to being in surgical stage 1 was 2.72[0.58 − 12.72] times higher and the odds of
having an outcome greater than surgical stage 2 relative to being in surgical stage
2 was 46.20[1.31− 1627.54] times higher among the patients diagnosed with FIGO
clinical stage 2 compared to the patients diagnosed with FIGO clinical stage 1,
after controlling for the effects of other predictors in the model. In addition, the
odds of having an outcome greater than surgical stage 1 relative to being in
surgical stage 1 was 2.09[0.21 − 20.30] times higher and the odds of having an
outcome greater than surgical stage 2 relative to being in surgical stage 2 was
4.88[0.17− 136.11] times higher among the patients considered to have the vaginal
region affected by the cancer (vaginal involvement) compared to the patients
without any vaginal involvement after controlling for the effects of other predictors
in the model. The odds of having an outcome greater than surgical stage 1 relative
to being in surgical stage 1 was 6.23[0.57 − 68.45] times higher and the odds of
having an outcome greater than surgical stage 2 relative to being in surgical stage
2 was 25.02[0.58− 1073.25] times higher among the patients considered to have the
parametrium region affected by the cervical cancer (parametrial involvement)
compared to the patients without any parametrial involvement after controlling for
the effects of other predictors in the model. The odds of having an outcome greater
that surgical stage 1 relative to being in surgical stage 1 was 3.01[0.99− 9.16] times
higher and in contrast, the odds of having an outcome greater than surgical stage
2 relative to being in surgical stage 2 was 0.24[0.01 − 5.00] times lower among the
patients with symptomatic vaginal discharge (Symptoms: Discharge) compared to
the patients who did not have symptomatic vaginal discharge after controlling for
the effects of other predictors in the model. The odds of having an outcome greater
than surgical stage 1 relative to being in surgical stage 1 was 2.28[0.74 − 7.06]
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times higher and in contrast, the odds of having an outcome greater than surgical
stage 2 relative to being in surgical stage 2 was 0.16[0.01 − 3.12] times lower
among the patients displaying symptomatic lower abdominal pain (Symptoms:
Pain) compared to the patients without symptomatic lower abdominal pain after
controlling for the effects of other predictors in the model.
4.2.3 Adjacent Category Logistic Regression Model
The Adjacent Category Logit model Ripley et al. (2016) is a special form of
generalized logit models that involves the simultaneous estimation of the effects of
predictor variables in pairs of adjacent categories. The ACL model involves the
ratio of two probabilities P [Y = yj] and P [Y = yj+1]. The proportional odds
assumption was tested by fitting the ACL model with and without the
proportional odds assumption.
The tables below shows the summary of the ACL null, univariate and multivariate
models with and without proportional odds. For the ACL univariate model with
proportional odds, we found that the FIGO clinical stage had a statistically
significant effect on the surgical stage response with a p-value of 0.00207. The
estimated logit regression coefficient for the FIGO clinical stage, β = −1.1740,
z-value=−3.080 and a p-value < 0.05 which showed that the FIGO clinical stage
upon diagnosis had a negative effect on each adjacent surgical stage response
category (common regression coefficients). The ACL univariate model without
proportional odds gave separate effects. We found that the estimated logit
regression coefficient β = −2.719, z-value=−2.650 and the p-value=0.008057
indicated that the log odds of being in surgical stage 2 versus surgical stage 1 was
−2.719 when the FIGO clinical stage increased by 1 unit, holding all other
predictors constant. Thus, the FIGO clinical stage had a significant effect on the
probability of being in surgical stage 2 versus surgical stage 1. However, the FIGO
clinical stage had no significant effect on the probability of being in surgical stage
1 versus surgical stage 0 with an estimated logit regression coefficient β = 0.057,
z-value=0.066 and the p-value=0.9477.
For the ACL multivariate model with proportional odds , only the FIGO clinical
stage with an estimated logit regression coefficient β = −1.044(0.509) and a
z-value=−2.05 had a negative effect on the surgical stage responses. Moreover, a
p-value of 0.04036 confirmed that it is a statistically significant predictor. The
remaining 4 predictors that were not statistically significant to the surgical stage
responses were vaginal involvement, parametrial involvement, symptomatic vaginal
discharge and lower abdominal pain. For the ACL multivariate model without
proportional odds, we get separate effects for the surgical stage responses. The
FIGO clinical stage had a negative effect on the probability of being classified
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under surgical stage 2 versus surgical stage 1. The estimated logit regression
coefficient β = −2.349(1.258), z-value = −1.903 and a p-value of 0.057 indicates
that it is not a significant predictor and the log-odds of being classified under
surgical stage 2 versus surgical stage 1 was −2.394 when the FIGO clinical stage
increased by 1 unit, holding all other predictors constant. In addition, the
symptomatic vaginal discharge predictor had a negative effect on the on the
probability of being classified under surgical stage 1 versus surgical stage 0. As
indicated by the estimated logit regression coefficient β = −1.261(0.657) and
z-value=−1.920 , the log odds of being classified under surgical stage 1 versus
surgical stage 0was −1.261. A p-value of 0.05488 shows that the predictor was not
significant to the surgical stage response. Clearly, of the 5 predictor variables, we
found no statistically significance to the probability of being classified either under
surgical stage 1 versus surgical stage 0 or surgical stage 2 versus surgical stage 1.
Coefficient Standard Errors z-statistic p-value
ACL Model with Proportional Odds
Intercept1 1.204 0.294 4.090 < 0.0000
Intercept2 0.405 0.408 0.993 < 0.3206
ACL Model without Proportional Odds
Intercept1 1.204 0.294 4.090 < 0.0000
Intercept2 0.405 0.408 0.993 0.3206
Table 4.18: The Summary for a ACL null model .
Coefficient Standard Errors z-statistic p-value
ACL Model with Proportional Odds
Intercept1 1.434 0.306 4.688 < 0.0000
Intercept2 0.914 0.485 1.887 < 0.0592
Clinical Stage 2 -1.174 0.381 -3.080 0.0021
ACL Model without Proportional Odds
Intercept1 1.196 0.317 3.779 < 0.0002
Intercept2 1.466 0.640 2.289 0.0221
Clinical Stage 1 0.057 0.862 0.066 0.9478
Clinical Stage 2 -2.719 1.026 -2.650 0.0081
Table 4.19: The Summary for a ACL univariate model with the inclusion of the
FIGO clinical stage predictor.
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Coefficient Standard Errors z-statistic p-value
ACL Model with Proportional Odds
Intercept1 1.937 0.397 4.874 < 0.0000
Intercept2 1.861 0.674 2.760 < 0.0058
Clinical Stage 2 -1.044 0.509 -2.050 0.0404
Vaginal Involvement: Yes -0.624 0.661 -0.943 0.3456
Parametrial Involvement: Yes -1.192 0.676 -1.762 0.078
Symptoms Discharge: Yes -0.668 0.409 -1.635 0.1021
Symptoms Pain: Yes -0.330 0.410 -0.806 0.4200
ACL Model without Proportional Odds
Intercept1 2.499 0.622 4.017 < 0.0001
Intercept2 0.994 1.044 0.953 0.3407
Clinical Stage 1 -0.006 1.032 -0.006 0.9950
Clinical Stage 2 -2.394 1.258 -1.903 0.057
Vaginal Involvement: Yes1 0.358 1.623 0.221 0.8253
Vaginal Involvement: Yes2 -1.420 1.552 -0.915 0.360
Parametrial Involvement: Yes1 -1.509 1.354 -1.114 0.2652
Parametrial Involvement: Yes2 -1.403 1.444 -0.972 0.3313
Symptoms Discharge: Yes1 -1.261 0.657 -1.920 0.0549
Symptoms Discharge: Yes2 0.327 1.027 0.319 0.7501
Symptoms Pain: Yes1 -1.209 0.659 -1.835 0.067
Symptoms Pain: Yes2 1.364 1.063 1.283 0.1996
Table 4.20: The Summary for a ACL multivariate model with the inclusion of the
5 predictors for Surgical Stage 1 and Stage 2.
Table 4.21 displays the goodness of fit statistics for the 3 models. An AIC of 121.72
indicates that the multivariate ACL model without proportional odds gave the best
fit for the cervical cancer data with further confirmation based on a residual deviance
and log likelihood ratio of 97.72 and −48.86 respectively. We carried out a VGAM
likelihood ratio test for the 2 multivariate ACL models and a chi-square p-value of
0.002981 indicating that both fits were significantly different from each other.
Deviance Log Likelihood AIC
Null ACL model 129.13 -64.56 133.13
Univariate ACL model 119.03 -59.51 125.03
Multivariate ACL model 106.13 -53.07 120.13
Deviance Log Likelihood AIC
Null ACL model 129.13 -64.56 133.13
Univariate ACL model 115.87 -57.94 123.87
Multivariate ACL model 97.72 -48.86 121.72
Table 4.21: Goodness of fit statistics for the ACL models with and without
Proportional Odds respectively
Equation 4.5 and 4.6 show the multivariate ACL models without proportional
odds assumptions for surgical stage 1 versus surgical stage 0 and surgical stage 2
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versus surgical stage 1. Based on the goodness of fit statistics, these 2 ACL models
without proportional odds were considered best in the classification of the surgical
stage outcomes.
log[P (SS = 0/SS = 1)][= 2.499(0.622)− 0.0065(1.032)clinicalstage+
0.358(1.623)V aginalinvolvement− 1.509(1.354)
Parametrialinvolvement− 1.261(0.657)
Symptom : Discharge− 1.261(0.657)Symptom : Pain]
(4.5)
log[P (SS = 1/SS = 2][= 0.994(1.044)− 2.394(1.258)clinicalstage
− 1.420(1.552)V aginalinvolvement− 1.403(1.444)Parametrialinvolvement
+ 0.327(1.027)Symptom : Discharge+ 1.364(1.063)Symptom : Pain]
(4.6)
The 3 ACL models with and without proportional odds were compared to
determine the model best fit for the cervical cancer data. The multivariate ACL
model with proportional odds had a misclassification rate of 32.00% and 37.32%
whereas the multivariate ACL model without proportional odds had a
misclassification rate of 29.33% and 37.03% when the train and validation datasets
were utilized respectively. Clearly, there was an increase in misclassification by
5.32% and 7.70% respectively.
Confusion matrices 4.22 and 4.23 derived for the train and validation set from
the multivariate ACL model without proportional odds gave an accuracy of
70.67%[95%CI : 59.02% − 80.62%] and 62.97%[95%CI : 62.01% − 63.92%]
respectively. With reference to table 4.24, the sensitivity for surgical stage 0, 1
and 2 was 0.727, 0.500 and 0.571 for the train set and 0.667, 0.176 and 0.142 for
the validation set. The specificity for surgical stage 0, 1 and 2 was 0.778, 0.808 and
0.912 for the train set and 0.330, 0.797 and for 0.870 for the validation set.
Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 48 0 2
Surgical stage one 13 1 1
Surgical stage two 5 1 4
Table 4.22: Confusion matrix of the multivariate ACL model without proportional
odds based on the train set.
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Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 6184 172 320
Surgical stage one 1884 45 90
Surgical stage two 1198 39 68
Table 4.23: Confusion matrix for the multivariate ACL model without proportional
odds based on the validation set
Sensitivity Specificity Prevalance
Train set
Surgical stage zero 0.7273 0.7778 0.8800
Surgical stage one 0.5000 0.8082 0.0267
Surgical stage two 0.5714 0.9118 0.0933
Validation set
Surgical stage zero 0.6674 0.3297 0.9266
Surgical stage one 0.1758 0.7974 0.0256
Surgical stage two 0.1423 0.8701 0.0478
Table 4.24: Sensitivity, Specificity and Prevalance for the multivariate ACL model
without proportional odds based on the train and validation set respectively.
Table 4.25 shows the summary of the odds ratios for the ACL model without
proportional odds. For the model 4.3 log[P (SS = 0/SS = 1)] and model 4.4
log[P (SS = 1/SS = 2)] respectively, for the patients diagnosed with FIGO clinical
stage 2, the odds of being classified into surgical stage 1 versus surgical stage 0 was
0.99[0.13 − 7.51] times lower and the odds of being classified into surgical stage 2
versus surgical stage 1 was 0.09[0.01 − 1.07] times lower than for the patients with
FIGO clinical stage 1 , holding all other predictors constant. Additionally, for the
patients whose vaginal region was affected by the cervical cancer, the odds of being
classified into surgical stage 1 versus surgical stage 0 was 1.43[0.06 − 34.47] times
higher and the odds of being classified into surgical stage 2 versus surgical stage 1
was 0.24[0.01− 5.06] times lower than for the patients without vaginal involvement,
holding all other predictors constant. For the patients who had the parametrium
affected by the cervical cancer, the odds of being classified under surgical stage 1
versus surgical stage 0 was 0.22[0.02 − 3.14] times lower and the odds of being
classified under surgical stage 2 versus surgical stage 1 was 0.25[0.01 − 4.17] times
lower than for patients without parametrial involvement, holding other predictors
constant. For the patients with symptomatic vaginal discharge, the odds of being
classified under surgical stage 1 versus surgical stage 0 was 0.28[0.08 − 1.03] times
lower and the odds of being classified under surgical stage 2 versus surgical stage 1
was 1.39[0.19− 10.39] times higher than for the patients without vaginal discharge,
whilst holding other predictors constant. For the patients with symptomatic
abdominal pain, the odds of being classified into surgical stage 1 versus surgical
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stage 0 was 0.30[0.08 − 1.09] times lower and the odds of being classified into
surgical stage 1 versus surgical stage 0 was 3.91[0.49− 31.42] times higher than for
the patients without abdominal pain, whilst holding all other predictors constant.
Predictor variables Odds ratio CI : 2.5 % CI: 97.5 %
(Intercept):1 12.17 3.60 41.20
(Intercept):2 2.70 0.35 20.91
Clinical.Stage 2:1 0.99 0.13 7.51
Clinical.Stage 2:2 0.09 0.01 1.07
Vaginal.Involvement Yes:1 1.43 0.06 34.47
Vaginal.Involvement Yes:2 0.24 0.01 5.06
Parametrial.Involvement Yes:1 0.22 0.02 3.14
Parametrial.Involvement Yes:2 0.25 0.01 4.17
Symptoms...Discharge Yes:1 0.28 0.08 1.03
Symptoms...Discharge Yes:2 1.39 0.19 10.39
Symptoms...Pain Yes:1 0.30 0.08 1.09
Symptoms...Pain Yes:2 3.91 0.49 31.42
Table 4.25: The Odds ratios for the ACL without proportional odds model
4.3 Regression Analysis based on the Predictive
approach
The information from these patients was utilized to simulate a dataframe of 10000
patients with similar characteristics to the 75 patients. We were able to generate a
random sample with a weighted sampling scheme by utilizing the sample() function
in R studio.
Table 4.26 lists the counts for the train and validation (test) data sets respectively
solely based on the simulated data.
Category Train dataset Validation dataset
Surgical stage 0 5341 1335
Surgical stage 1 1616 403
Surgical stage 2 1044 261
Table 4.26: Counts for patients in each surgical stage based on simulated data only
4.3.1 Polytomous (Multinomial) Logistic Regression Model
The reference category for the multinomial (polytomous) model was surgical stage
0. The 3 models fitted were the null model, univariate model and the multivariate
model. We determined the presence of a relationship between the response variable
and a combination of predictor variables by performing a likelihood ratio test. The
results showed that the statistical significance of the probability of the model
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likelihood ratio (0.575) was 0.7502 indicating that there was no significant
difference between the null (no predictors) and the univariate MLR model (FIGO
clinical stage only). Moreover, the probability of the model likelihood ratio (7.834)
was 0.4499 showing there was no significant difference between the univariate and
the multivariate MLR models.
Table 4.27 shows the fitted univariate MLR model with the international FIGO
clinical stage as the sole predictor variable. The output shows that the log odds of
being in surgical stage 1 compared to surgical stage 0 (reference category)
decreased by 0.031 if moving from clinical stage 1 to clinical stage 2 and the log
odds of being in surgical stage 2 compared to surgical stage 0(reference category)
increased by 0.043 if moving from clinical stage 1 to clinical stage 2. The
intercepts show the log odds for surgical stage 0 (reference category).
Table 4.28 shows the summary for a multivariate model built with the inclusion of
the 5 statistically significant predictors. The first model compares surgical stage 1
to surgical stage 0 (reference category)and the second model compares surgical
stage 2 to surgical stage 0. We found that all the predictor variables were
statistically insignificant and not associated to the surgical stage outcomes.
Coefficient Standard Errors z-statistic p-value
Surgical Stage 1
Intercept -1.189 0.032 -37.377 0.00000
Clinical Stage 2 -0.031 0.071 -0.444 0.65707
Surgical Stage 2
Intercept -1.641 0.038 -43.019 0.00000
Clinical Stage 2 0.043 0.083 0.517 0.60522
Table 4.27: Summary for a univariate MLR model built with the inclusion of the
FIGO clinical stage only.
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Coefficient Standard Errors z-statistic p-value
Surgical Stage 1
Intercept -1.202 0.049 -24.747 0.00000
Clinical Stage 2 -0.033 0.071 -0.462 0.64397
Vaginal Involvement: Yes 0.072 0.091 0.797 0.42568
Parametrial Involvement: Yes -0.120 0.107 -1.125 0.26071
Symptoms Discharge: Yes 0.011 0.057 0.197 0.84363
Symptoms Pain: Yes 0.024 0.058 0.416 0.67733
Surgical Stage 2
Intercept -1.604 0.057 -28.025 0.00000
Clinical Stage 2 0.043 0.083 0.519 0.60391
Vaginal Involvement: Yes 0.155 0.105 1.477 0.13956
Parametrial Involvement: Yes 0.082 0.120 0.685 0.49357
Symptoms Discharge: Yes -0.105 0.069 -1.519 0.12886
Symptoms Pain: Yes -0.045 0.069 -0.653 0.51358
Table 4.28: Summary for a multivariate MLR model built with the inclusion of the
5 statistically significant predictors.
Table 4.7 displays the goodness of fit statistics for the 3 models. The full MLR
model with the 5 statistically significant predictor variables had the highest AIC
(with the lowest AIC being the null MLR model of 13743.34. The full MLR model
gave the lowest residual deviance of 13754.93 with the highest log likelihood ratio
of −6865.47. Thus, the multivariate multinomial logistic model was considered a
better predictive fit for the simulated data compared to the univariate and null
models.
Deviance Log Likelihood AIC
Null MLR model 13739.34 -6869.67 13743.34
Univariate MLR model 13738.77 -6869.38 13746.77
Multivariate MLR model 13730.93 -6865.47 13754.93
Table 4.29: Goodness of fit statistics for the MLR models
Equation 4.7 and 4.8 show the multivariate MLR models for surgical stage 1 and
surgical stage 2 both compared to the surgical stage 0 (the reference category).
Based on the goodness-of-fit statistics, these 2 multivariate MLR models were
considered best in the classification of the surgical stage outcomes.
log[P (SS = 1|SS = 0)][= −1.202(0.049)− 0.033(0.071)Clinicalstage+
0.072(0.091)V aginalinvolvement− 0.120(0.107)
Parametrialinvolvement+ 0.011(0.057)
Symptom : Discharge+ 0.024(0.058)Symptom : Pain]
(4.7)
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log[P (SS = 2|SS = 0][= −1.604(0.057) + 0.043(0.083)clinicalstage
+ 0.155(0.105)V aginalinvolvement+ 0.082(0.120)Parametrialinvolvement
− 0.105(0.069)Symptom : Discharge− 0.045(0.069)Symptom : Pain]
(4.8)
Confusion matrix 4.30 derived for the validation set gave an accuracy of
66.78%[95%CI : 64.67% − 68.85%] . With reference to table 4.31, the sensitivity
for surgical stage 0, 1 and 2 are listed for the validation set.
Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 1335 403 261
Surgical stage one 0 0 0
Surgical stage two 0 0 0




Surgical stage zero 1.0000 0.0000 0.6678
Surgical stage one 0.0000 1.0000 0.2016
Surgical stage two 0.0000 1.0000 0.1306
Table 4.31: Sensitivity, specificity and prevalance for the multivariate MLR model
based on the validation set.
Table 4.32 shows the odds ratios extracted from the MLR multivariate model.
Odds ratio 2.5 % 97.5 %
(Intercept):1 0.30 0.27 0.33
(Intercept):2 0.20 0.18 0.22
Clinical.Stage 2:1 0.97 0.84 1.11
Clinical.Stage 2:2 1.04 0.89 1.23
Vaginal.Involvement Yes:1 1.07 0.90 1.28
Vaginal.Involvement Yes:2 1.17 0.95 1.43
Parametrial.Involvement Yes:1 0.89 0.72 1.09
Parametrial.Involvement Yes:2 1.09 0.86 1.37
Symptoms...Discharge Yes:1 1.01 0.90 1.13
Symptoms...Discharge Yes:2 0.90 0.79 1.03
Symptoms...Pain Yes:1 1.02 0.92 1.15
Symptoms...Pain Yes:2 0.96 0.84 1.09
Table 4.32: The odds ratios for the MLR multivariate model were extracted.
With the best fit model being the multivariate MLR model, the odds ratios were
extracted from the models. The odds ratios 4.32 extracted from the multivariate
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multinomial logistic model which displayed the best fit model for the simulated
data. The odds of being classified into surgical stage 1 over surgical stage 0 was
0.97 [CI: 0.84 − 1.11] lower for patients diagnosed with FIGO clinical stage 2
versus those diagnosed with FIGO clinical stage 1 while holding all other
predictors constant. Moreover, the odds of being classified into surgical stage 2
over surgical stage 0 was 1.04 CI:[0.89 − 1.23] times higher for patients diagnosed
with FIGO clinical stage 2 versus those diagnosed with FIGO clinical stage 1 while
holding all other predictors constant. The odds of being classified into surgical
stage 1 over surgical stage 0 was 1.07 CI:[0.90− 1.28] times higher and the odds of
being in surgical stage 2 over surgical stage 0 was1.17 CI: [0.95− 1.43] times higher
for patients with the vaginal region observed to be affected by the cancer during
diagnosis versus those without any vaginal involvement while holding all other
predictors constant. The odds of being classified into surgical stage 1 over surgical
stage 0 was 0.89 CI: [0.72 − 1.09] times lower and the odds of being classified into
surgical stage 2 over surgical stage 0 was 1.09 CI: [0.86 − 1.37] times higher for
patients with the parametrial region affected by the cancer versus those without
any parametrial involvement while holding other predictors constant. The odds of
being classified into surgical stage 1 over surgical stage 0 was 1.01 CI: [0.90− 1.13]
times higher and the odds of being classified into surgical stage 2 over surgical
stage 0 was 0.90 CI: [0.79 − 1.03] times lower for the patients with symptomatic
vaginal discharge during diagnosis versus those without the symptomatic vaginal
discharge, holding all other predictors constant. The odds of being classified into
surgical stage 1 over surgical stage 0 was 1.02 CI:[0.92 − 1.15] times higher and in
contrast, the odds of being into surgical stage 2 over surgical stage 0 was 0.96
CI:[0.84 − 1.09] times lower for the patients with symptomatic lower abdominal
pain versus those without any pain, holding all other predictors constant.
4.3.2 Continuation Ratio Model
Continuation Ratio Model with and without Proportional Odds
The tables below show the output for the CR null, univariate and multivariate
models with and without proportional odds respectively. The univariate CR model
with and without proportional odds output considered the FIGO clinical stage as
the only predictor. Clearly, the CR univariate model with proportional odds
showed that the FIGO clinical stage had no significant effect on the surgical stage
response with a p-value of 0.9212 when the regression coefficient was common. The
estimated log regression coefficient for the FIGO clinical stage ,
β = 0.004(0.038), z = 0.099 and p = 0.9212 showed that the FIGO clinical stage
upon diagnosis had a positive effect on the surgical stage responses. The CR
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model without proportional odds gave separate effects. All the 5 predictors were
found not to be statistically significant. For having a surgical stage outcome
greater than surgical stage 1 relative to being in surgical stage 1, the estimated log
regression coefficient for the FIGO clinical stage was β = 0.027(0.049), z-value=
0.555 and a p-value of 0.579 indicating that the FIGO clinical stage had no
significant effect on the surgical stage 1 responses. In addition, having a surgical
stage outcome greater than surgical stage 2 relative to being in surgical stage 2,
the estimated logit regression coefficient for FIGO clinical stage was
β = −0.030(0.058), z-value=−0.517 and a p-value of 0.605 indicating that the
FIGO clinical stage had no significant effect on surgical stage 2 responses.
The multivariate CR model with and without proportional odds output with the 5
predictors that were found to be statistically significant were included.For the CR
multivariate model with proportional odds, the FIGO clinical stage estimated log
regression coefficient, β = 0.004(0.038), z-value=0.116 had a positive effect on the
surgical stage responses. In contrast, a p-value of 0.9079 showed that the FIGO
clinical stage is not a statistically significant predictor for having a surgical stage
outcome greater than surgical stage 1 relative to being in surgical stage 1 as well
as having a surgical stage outcome greater than surgical stage 2 relative to being
in surgical stage 2. The remaining 4 predictors that were not statistically
significant to the surgical stage responses were the vaginal involvement, the
parametrial involvement, symptomatic vaginal discharge and lower abdominal
pain. For the CR multivariate model without proportional odds, we got separate
effects for the surgical stage responses.For having a surgical stage outcome greater
than surgical stage 1 relative to being in surgical stage 1, the FIGO clinical stage
and the parametrial involvement had no effect on the surgical stage outcome with
an estimated logit regression coefficient of β = 0.028(0.049), z-value=0.574 and
p-value of 0.5660 and an estimated logit regression coefficient of β = 0.134(0.105),
z-value=1.277 and p-value of 0.2017 respectively. The estimated logit coefficients
for the vaginal involvement,symptomatic discharge and symptomatic lower
abdominal pain were not statistically significant with estimated logit regression
coefficients of β = −0.046(0.089), z-value=−0.514 and p-value of 0.6073,
β = −0.028(0.056), z-value=−0.503 and p-value of 0.6150 and β = −0.031(0.056),
z-value=−0.554 and p-value of 0.5799 . Also, it was clear that for having a surgical
stage outcome greater than surgical stage 2 relative to being in surgical stage 2,
the FIGO clinical stage had a no effect and was not statistically significant with an
estimated logit regression coefficient of β = −0.030(0.058), z-value=−0.513 and
p-value of 0.0608. The estimated logit regression coefficients for vaginal
involvement,parametrial involvement, symptomatic vaginal discharge and
symptomatic lower abdominal pain were not statistically significant with no effect
on the surgical stage responses and were found to be β = −0.156(0.105),
68
z-value=−1.490 and p-value of 0.1362 ,β = −0.084(0.119), z-value=−0.701 and
p-value of 0.4835,β = 0.106(0.069), z-value=1.530 and p-value of 0.1261 and
β = 0.046(0.069), z-value=0.666 and p-value of 0.5055.
Coefficient Standard Errors z-statistic p-value
CR Model with Proportional Odds
Intercept1 1.376 0.032 43.120 0.00000
Intercept2 1.634 0.037 43.870 0.0000
Clinical Stage 2 0.004 0.038 0.099 0.92117
CR Model without Proportional Odds
Intercept1 1.385 0.035 40.063 0.00000
Intercept2 1.620 0.041 39.226 0.00000
Clinical Stage 1 0.027 0.049 0.555 0.579
Clinical Stage 2 -0.030 0.058 -0.517 0.605
Table 4.33: The Summary for a CR univariate model with the inclusion of the FIGO
clinical stage predictor.
Coefficient Standard Errors z-statistic p-value
CR Model with Proportional Odds
Intercept1 1.372 0.042 32.565 0.00000
Intercept2 1.630 0.046 35.200 0.00000
Clinical Stage 2 0.004 0.038 0.116 0.90789
Vaginal Involvement: Yes -0.090 0.068 -1.333 0.18248
Parametrial Involvement: Yes 0.043 0.079 0.541 0.58828
Symptoms Discharge: Yes 0.025 0.044 0.580 0.56219
Symptoms Pain: Yes 0.000 0.044 -0.011 0.99160
CR Model without Proportional Odds
Intercept1 1.405 0.050 28.170 0.00000
Intercept2 1.583 0.059 26.671 0.00000
Clinical Stage 1 0.028 0.049 0.574 0.56600
Clinical Stage 2 -0.030 0.058 -0.513 0.060794
Vaginal Involvement: Yes1 -0.046 0.089 -0.514 0.60731
Vaginal Involvement: Yes2 -0.156 0.105 -1.490 0.13616
Parametrial Involvement: Yes1 0.134 0.105 1.277 0.20165
Parametrial Involvement: Yes2 -0.084 0.119 -0.701 0.48352
Symptoms Discharge: Yes1 -0.028 0.056 -0.503 0.61504
Symptoms Discharge: Yes2 0.106 0.069 1.530 0.12605
Symptoms Pain: Yes1 -0.031 0.056 -0.554 0.57992
Symptoms Pain: Yes2 0.046 0.069 0.666 0.50551
Table 4.34: The Summary for a CR multivariate model with the inclusion of the 5
predictors for Surgical Stage 1 and Stage 2.
Table 4.35 and 4.36 show the goodness of fit statistics for the 2 CR multivariate
models (with and without proportional odds). An AIC of 13743.34 shows that the
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null CR models would be a good fit. However, a low residual deviance and
likelihood ratio of 13730.89 and −6865.44 respectively show that the multivariate
CR model without proportional odds is a better fit. Moreover, the VGAM
likelihood ratio test was carried out for the 2 CR multivariate models and a
chi-square p-value of 0.303 showed that the fits were not significantly different and
thus, the multivariate CR model without proportional odds was found to be
adequate.
Deviance Log Likelihood AIC
Null CR model 13739.34 -6869.67 13743.34
Univarite CR model 13739.33 -6869.67 13745.33
Multivariate CR model 13736.92 -6868.46 13750.92
Table 4.35: Goodness of fit statistics for the CR models with Proportional Odds
Deviance Log Likelihood AIC
Null CR model 13739.34 -6869.67 13743.34
Univariate CR model 13738.77 -6869.38 13746.77
Multivariate CR model 13730.89 -6865.44 13754.89
Table 4.36: Goodness of fit statistics for the CR models without Proportional Odds
The multivariate CR model with proportional odds did give better goodness of fit
statistics. However, all the 5 predictors were found not to be statistically
significant to the prediction of the surgical stage.A log likelihood ratio test for the
null and univariate CR models with PPOs versus the full CR model with PPOs
each gave a p-value of 0.788 and 0.660 respectively showing that their was no
significant differences among the 3 models.
Moreover, the log likelihood ratio test for the null and univariate CR models
without PPOs versus the full CR model without PPOs each gave a p-value of
0.584 and 0.445 respectively showing that their was no significant differences
among the 3 models.
Below is the confusion matrix 4.3.2 for the multivariate CR model without PPOs.
The model gave an accuracy of 66.78% [CI: 64.67% - 68.85%].
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Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 1335 0 0
Surgical stage one 403 0 0
Surgical stage two 261 0 0
Table 4.37: Confusion matrix of the multivariate CR model without proportional
odds based on the validation set.
Equation 4.9 and 4.10 show the multivariate CR model without proportional odds
assumptions for surgical stage 1 and surgical stage 2. Based on the goodness-of-fit
statistics, these 2 CR models without proportional odds were considered best in the
classification of the surgical stage outcomes.
log[P (SS = 1|SS ≥ 1)][= 1.405(0.050) + 0.028(0.049)clinicalstage−
0.046(0.089)V aginalinvolvement+ 0.134(0.105)
Parametrialinvolvement− 0.028(0.056)
Symptom : Discharge− 0.031(0.056)Symptom : Pain]
(4.9)
log[P (SS = 2|SS ≥ 2)][= 1.583(0.059)− 0.030(0.058)clinicalstage−
0.156(0.105)V aginalinvolvement− 0.084(0.119)
Parametrialinvolvement+ 0.106(0.069)
Symptom : Discharge+ 0.046(0.069)Symptom : Pain]
(4.10)
Odds ratio 2.5 % 97.5 %
(Intercept):1 4.076 3.697 4.495
(Intercept):2 4.867 4.333 5.467
Clinical.Stage 2:1 1.028 0.934 1.132
Clinical.Stage 2:2 0.970 0.865 1.088
Vaginal.Involvement Yes:1 0.955 0.803 1.137
Vaginal.Involvement Yes:2 0.855 0.696 1.051
Parametrial.Involvement Yes:1 1.144 0.931 1.405
Parametrial.Involvement Yes:2 0.920 0.728 1.162
Symptoms...Discharge Yes:1 0.972 0.870 1.086
Symptoms...Discharge Yes:2 1.111 0.971 1.272
Symptoms...Pain Yes:1 0.969 0.868 1.083
Symptoms...Pain Yes:2 1.047 0.915 1.198
Table 4.38: The odds ratios for the CR multivariate model without proportional
odds were extracted.
By utilizing the multiclass.roc() function, we found that the multi-class area under
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the curve for the univariate and multivariate CR models without PPOs were
0.4996 and 0.5071 respectively
.For the model 4.9 logit[P (SS = 1|SS ≥ 1] and model 4.10
logit[P (SS = 2|SS ≥ 2] respectively, the odds of having an outcome greater than
surgical stage 1 relative to being in surgical stage 1 was 1.028[0.93 − 1.13] times
higher and the odds of having an outcome greater than surgical stage 2 relative to
being in surgical stage 2 was 0.97[0.87 − 1.09] times lower among the patients
diagnosed with FIGO clinical stage 2 compared to the patients diagnosed with
FIGO clinical stage 1, after controlling for the effects of other predictors in the
model. In addition, the odds of having an outcome greater than surgical stage 1
relative to being in surgical stage 1 was 0.96[0.80− 1.14] times lower and the odds
of having an outcome greater than surgical stage 2 relative to being in surgical
stage 2 was 0.86[0.70 − 1.05] times lower among the patients considered to have
the vaginal region affected by the cancer (vaginal involvement) compared to the
patients without any vaginal involvement after controlling for the effects of other
predictors in the model. The odds of having an outcome greater than surgical
stage 1 relative to being in surgical stage 1 was 1.14[0.93 − 1.41] times higher and
the odds of having an outcome greater than surgical stage 2 relative to being in
surgical stage 2 was 0.92[0.73− 1.16] times lower among the patients considered to
have the parametrium region affected by the cervical cancer (parametrial
involvement) compared to the patients without any parametrial involvement after
controlling for the effects of other predictors in the model. The odds of having an
outcome greater that surgical stage 1 relative to being in surgical stage 1 was
0.97[0.87 − 1.09] times lower and in contrast, the odds of having an outcome
greater than surgical stage 2 relative to being in surgical stage 2 was
1.11[0.97 − 1.27] times higher among the patients with symptomatic vaginal
discharge (Symptoms: Discharge) compared to the patients who did not have
symptomatic vaginal discharge after controlling for the effects of other predictors
in the model. The odds of having an outcome greater than surgical stage 1 relative
to being in surgical stage 1 was 0.97[0.87 − 1.08] times lower and in contrast, the
odds of having an outcome greater than surgical stage 2 relative to being in
surgical stage 2 was 1.05[0.92 − 1.20] times higher among the patients displaying
symptomatic lower abdominal pain (Symptoms: Pain) compared to the patients
without symptomatic lower abdominal pain after controlling for the effects of other
predictors in the model.
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4.3.3 Adjacent Category Logistic Regression Model
Adjacent Category Logistic Regression Model with and without
Proportional Odds
The tables below shows the summary of the ACL null, univariate and multivariate
models with and without proportional odds. For the ACL univariate model with
proportional odds, we found that all the 5 predictors were not statistically
significant. The FIGO clinical stage had no statistically significant effect on the
surgical stage response with a p-value of 0.69. The estimated logit regression
coefficient for the FIGO clinical stage, β = 0.015(0.039), z-value=0.387 and a
p-value 0.69 which showed that the FIGO clinical stage upon diagnosis had no
effect on each adjacent surgical stage response category (common regression
coefficients). The ACL univariate model without proportional odds gave separate
effects. We found that the estimated logit regression coefficient β = 0.030(0.070),
z-value=−0.433 and the p-value=0.665 indicated that the log odds of being in
surgical stage 1 versus surgical stage 0 was 0.030 when the FIGO clinical stage
increased by 1 unit, holding all other predictors constant. In addition, the
estimated logit regression coefficient β = −0.009(0.098), z-value=−0.090 and the
p-value=0.928 indicated that the log odds of being in surgical stage 2 versus
surgical stage 1 was −0.009 when the FIGO clinical stage increased by 1 unit,
holding all other predictors constant. However, the FIGO clinical stage had no
significant effect on the probability of being in surgical stage 1 versus surgical
stage 0 and on the probability of being in surgical stage 2 versus surgical stage 1 .
For the ACL multivariate model with proportional odds , the 5 predictors were not
statistically significant to the surgical stage responses. For the ACL multivariate
model without proportional odds, we get separate effects for the surgical stage
responses. The FIGO clinical stage had no effect on the probability of being
classified under surgical stage 1 versus surgical stage 0 and on the probability of
being classified under surgical stage 2 versus surgical stage 1 with the estimated
logit regression coefficient β = 0.031(0.070), z-value = 0.435 and a p-value of 0.664
indicating that it is not a significant predictor and the log-odds of being classified
under surgical stage 2 versus surgical stage 1 being −0.011(0.098),z-value = −0.107
and a p-value of 0.915 when the FIGO clinical stage increased by 1 unit, holding
all other predictors constant. Moreover, the remaining 4 predictor variables had no
statistical significance to the probability of being classified either under surgical
stage 1 versus surgical stage 0 or surgical stage 2 versus surgical stage 1.
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Coefficient Standard Errors z-statistic p-value
ACL Model with Proportional Odds
Intercept1 1.196 0.029 42.11 < 2e - 16
Intercept2 0.437 0.040 11.00 < 2e - 16
ACL Model without Proportional Odds
Intercept1 1.196 0.029 42.11 < 2e - 16
Intercept2 0.437 0.040 11.00 < 2e - 16
Table 4.39: The Summary for a ACL null model.
Coefficient Standard Errors z-statistic p-value
ACL Model with Proportional Odds
Intercept1 1.192 0.030 40.396 < 2e - 16
Intercept2 0.434 0.040 10.716 < 2e - 16
Clinical Stage 2 0.015 0.039 0.387 0.69
ACL Model without Proportional Odds
Intercept1 1.189 0.032 37.308 < 2e - 16
Intercept2 0.439 0.045 9.843 < 2e - 16
Clinical Stage 1 0.030 0.070 0.433 0.665
Clinical Stage 2 -0.009 0.098 -0.090 0.928
Table 4.40: The Summary for a ACL univariate model with the inclusion of the
FIGO clinical stage predictor.
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Coefficient Standard Errors z-statistic p-value
ACL Model with Proportional Odds
Intercept1 1.181 0.036 33.196 < 2e - 16
Intercept2 0.424 0.045 9.425 < 2e - 16
Clinical Stage 2 0.014 0.039 0.372 0.710
Vaginal Involvement: Yes -0.059 0.050 -1.181 0.238
Parametrial Involvement: Yes -0.075 0.056 -1.341 0.180
Symptoms Discharge: Yes 0.042 0.032 1.330 0.183
Symptoms Pain: Yes 0.014 0.032 0.430 0.667
ACL Model without Proportional Odds
Intercept1 1.181 0.048 24.539 < 2e - 16
Intercept2 0.425 0.067 6.337 2.35e - 10
Clinical Stage 1 0.031 0.070 0.435 0.6637
Clinical Stage 2 -0.011 0.098 -0.107 0.9149
Vaginal Involvement: Yes1 -0.053 0.092 -0.577 0.5642
Vaginal Involvement: Yes2 -0.068 0.126 -0.540 0.5893
Parametrial Involvement: Yes1 0.037 0.106 0.353 0.7241
Parametrial Involvement: Yes2 -0.239 0.141 -1.698 0.0895
Symptoms Discharge: Yes1 0.020 0.058 0.353 0.7240
Symptoms Discharge: Yes2 0.077 0.081 0.946 0.3440
Symptoms Pain: Yes1 0.005 0.058 0.081 0.9351
Symptoms Pain: Yes2 0.028 0.081 0.342 0.7325
Table 4.41: The Summary for a ACL multivariate model with the inclusion of the
5 predictors for Surgical Stage 1 and Stage 2.
Tables 4.42 and 4.43 display the goodness of fit statistics for the 3 ACL multivariate
models with and without proportional odds. An AIC of 13743.34 indicates that the
null ACL models would be a good fit. However, the multivariate ACL without
proportional odds had the lowest residual deviance and the highest log likelihood
ratio of 13732.25 and−6866.13 respectively. We carried out a VGAM likelihood ratio
test for the 2 multivariate ACL models and a chi-square p-value of 0.865 indicating
that both fits were not significantly different from each other.
Deviance Log Likelihood AIC
Null ACR model 13739.34 -6869.67 13743.34
Univariate ACL model 13739.19 -6869.60 13745.19
Multivariate ACL model 13734.14 -6867.07 13748.14
Table 4.42: Goodness of fit statistics for the ACL models with Proportional Odds
Deviance Log Likelihood AIC
Null ACL model 13739.34 -6869.67 13743.34
Univariate ACL model 13739.12 -6869.56 13747.12
Multivariate ACL model 13732.25 -6866.13 13756.25
Table 4.43: Goodness of fit statistics for the ACL models without Proportional Odds
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The 3 ACL models with and without proportional odds were compared to
determine the model best fit for the simulated data. The multivariate ACL model
with proportional odds had a misclassification rate of 33.22% and the multivariate
ACL model without proportional odds had a misclassification rate of 33.22% when
the validation datasets were utilized.
Confusion matrices 4.3.3 derived for the validation set from the multivariate ACL
model without proportional odds gave an accuracy of
66.78%[95%CI : 64.67%− 68.85%].
Actual
Surgical stage zero Surgical stage one Surgical stage two
Prediction
Surgical stage zero 1335 0 0
Surgical stage one 403 0 0
Surgical stage two 261 0 0
Table 4.44: Confusion matrix of the multivariate ACL model without proportional
odds based on the validation set.
Equation 4.11 and 4.12 show the multivariate ACL model without proportional
odds for surgical stage 1 versus surgical stage 0 and surgical stage 2 versus surgical
stage 1.
log[P (SS = 0|SS = 1)][= 1.181(0.048) + 0.031(0.070)clinicalstage−
0.053(0.092)V aginalinvolvement+ 0.037(0.106)
Parametrialinvolvement+ 0.020(0.058)
Symptom : Discharge+ 0.005(0.058)Symptom : Pain]
(4.11)
log[P (SS = 1|SS = 2][= 0.425(0.067)− 0.011(0.098)clinicalstage
− 0.068(0.126)V aginalinvolvement− 0.239(0.141)Parametrialinvolvement
+ 0.077(0.081)Symptom : Discharge+ 0.028(0.081)Symptom : Pain]
(4.12)
Table 4.45 shows the summary of the odds ratios for the ACL model without
proportional odds based on the simulated data. For the model 4.11 log[P (SS =
0/SS = 1)] and model 4.12 log[P (SS = 1/SS = 2)] respectively, for the patients
diagnosed with FIGO clinical stage 2, the odds of being classified into surgical stage
1 versus surgical stage 0 was 1.03[0.90 − 1.18] times higher and the odds of being
classified into surgical stage 2 versus surgical stage 1 was 0.99[0.82 − 1.20] times
lower than for the patients with FIGO clinical stage 1 , holding all other predictors
constant. Additionally, for the patients whose vaginal region was affected by the
cervical cancer, the odds of being classified into surgical stage 1 versus surgical stage
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0 was 0.95[0.79−1.14] times lower and the odds of being classified into surgical stage 2
versus surgical stage 1 was 0.93[0.73−1.20] times lower than for the patients without
vaginal involvement, holding all other predictors constant. For the patients who had
the parametrium affected by the cervical cancer, the odds of being classified under
surgical stage 1 versus surgical stage 0 was 1.04[0.84 − 1.28] times higher and the
odds of being classified under surgical stage 2 versus surgical stage 1 was 0.79[0.60−
1.04] times lower than for patients without parametrial involvement, holding other
predictors constant. For the patients with symptomatic vaginal discharge, the odds
of being classified under surgical stage 1 versus surgical stage 0 was 1.02[0.91 −
1.14] times higher and the odds of being classified under surgical stage 2 versus
surgical stage 1 was 1.08[0.92 − 1.27] times higher than for the patients without
vaginal discharge, whilst holding other predictors constant. For the patients with
symptomatic abdominal pain, the odds of being classified into surgical stage 1 versus
surgical stage 0 was 1.00[0.90 − 1.12] times higher and the odds of being classified
into surgical stage 1 versus surgical stage 0 was 1.03[0.88−1.20] times higher than for
the patients without abdominal pain, whilst holding all other predictors constant.
Predictor variables Odds ratio 2.5 % 97.5 %
(Intercept):1 3.26 2.97 3.58
(Intercept):2 1.53 1.34 1.74
Clinical.S2:1 1.03 0.90 1.18
Clinical.S2:2 0.99 0.82 1.20
Vaginal.InvolvementYes:1 0.95 0.79 1.14
Vaginal.InvolvementYes:2 0.93 0.73 1.20
Parametrial.InvolvementYes:1 1.04 0.84 1.28
Parametrial.InvolvementYes:2 0.79 0.60 1.04
Symptoms...DischargeYes:1 1.02 0.91 1.14
Symptoms...DischargeYes:2 1.08 0.92 1.27
Symptoms...PainYes:1 1.00 0.90 1.12
Symptoms...PainYes:2 1.03 0.88 1.20
Table 4.45: The Odds ratios for the ACL without proportional odds model
By utilizing the multiclass.roc() function, we found that the multi-class area under
the curve for the multivariate ACL model without PPOs was 0.5214 .
Table 4.46 shows the values of the area under the curve (AUC) for the best fits of
each model. In his article, Lans (2019) describes the AUC metric as the
probability that an observation with a positive class will have a greater predicted
probability than an observation in a negative class. The AUC is considered similar
to the R-square value in logistic regression. The AUC results are within 0.5
indicating that the 3 models were unable to discriminate between the surgical
stage categories.
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Ordinal Multivariate Model Multi-class ROC (area under the curve)
Multinomial Logistic Regression model 0.506
Continuation Ratio
without Proportional Odds Model 0.507
Adjacent Category Logistic
without proportional odds model 0.521





Ordinal techniques utilize the ordering of the levels and do not assume equal
spacing between the levels of the response variable as stated by Meisner et al.
(2018). The World Health Organization stated that the availability of effective
treatment amongst women 30 − 49 years of age is not being captured. Still, the
aim of cervical cancer screening is to detect the pre-cancerous changes on the
cervix which may lead to cancer. The objective of this study was to evaluate the
predictive performance of 3 regression models for ordinal responses on the surgical
stage of women treated surgically for invasive cervical cancer based on an
inferential and predictive approach. The inferential approach relied on utilizing the
same data and in contrast, the predictive approach required the use of simulated
data with similar characteristics to the original data.
The results may provide an understanding of the future possibilities of using
predictive algorithms in the Kenyan oncology setting and furthermore, allow for
informed based surgical treatment patient selection. In our study, a bivariate
analysis was carried out to determine the factors associated with the surgical stage
after surgical treatment of cervical cancer. Thereafter, the relationship between
the surgical stage outcomes and 5 statistically significant predictor variables were
investigated by developing, validating and comparing the odds ratios of 3 types of
regression models for ordinal responses. The relationships between the surgical
stage and 5 statistically significant variables were investigated by applying
regression models and comparing the odds ratios.The main point of interest in this
discussion was to assess the benefit and possibility of utilizing ordinal regression
models.
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5.2 Application to surgically-treated cervical
cancer patients
Inferential Approach
It is important to understand that the main aim of surgical treatment for early
stage cervical cancer is to extract all the cancer before the cancer spreads to the
lymph nodes and tissues around the tumour. Successful surgical treatment
outcomes result in cost effectiveness and proper utilization of resources by avoiding
the need for alternative therapy. Thus, consider the question: “Among the 3
regression models for ordinal responses, which model best estimates and predicts
the surgical stage prior to surgical treatment of cervical cancer?” The results
indicated that the FIGO clinical stage, parametrial involvement, vaginal
involvement, symptomatic vaginal discharge and lower abdominal pains were
statistically significant and independently associated with the surgical stage and
could be taken into account when determining whether surgery would be the most
effective mode of treatment therapy to be assigned to a patient with confirmed
cervical cancer. Such would considerably increase the efficiency and effectiveness of
the surgical treatment of cervical cancer.In addition, the findings from this study
suggest that among the 3 ordinal regression models, the continuation ratio model
without proportional odds was found to best classify the surgical stages of the
patients with a misclassification rate of 33.22% . Although the 3 models are similar
in that they fit multiple simultaneous binary logits, there is some restructuring of
categories. The CR model fits 2 logits on each consecutive step; in terms of
dummy variables, with the increasing ’0’ category, the ’1’ category is considered
the higher category. The MLR model compares each of the surgical stages 1 to 2
with surgical stage 0 (the reference category) in 2 simultaneous logit models and
the ACL model fits logit models to 2 adjacent pairs of surgical stage categories.
The results showed that the inferential approach focused on statistical significance
of the FIGO clinical stage on women classified under surgical stage 2. However, the
small sample size of the train set could have brought about bias and uncertainty on
the results.
The results further showed that for each model, the multivariate models took
precedence which indicated that a combination of predictors could best determine
the surgical stage outcome of a patient prior to surgery.
The multivariate CR model without proportional odds presented an AIC value of
118.89 indicating that it would be the best model to select for the cervical cancer
data. The study demonstrated a similarity between the MLR and ACL model.
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The multivariate MLR and ACL model without proportional odds had similar
likelihood ratios of −48.86 whilst the CR model without proportional odds had a
likelihood ratio of −47.44 showing that the later model was statistically different
from the 2 models. In terms of model selection, the multivariate MLR and ACL
model without proportional odds presented similar AIC values of 121.72. de Rooij
(2019) stated that when βj is utilized instead of a single β, then the ACL model
becomes equivalent to the MLR model. Also, the similarity in AIC statistic values
could be attributed to the small sample size of the cervical cancer data. This fact
could explain the similarity in the goodness-of-fit statistics between the MLR and
ACL models. In order to test the proportional odds assumption, the CR model
and the ACL models were fitted with and without proportional odds. The
accuracy of the CR model with and without proportional odds was 70.67% and
69.33% respectively. However, the goodness-of-fit statistics showed that the CR
model without proportional odds gave the lowest deviance of 94.89 and a low AIC
statistic of 118.72. On analyzing the results, the CR null models with and without
proportional odds gave similar coefficients and negligible differences were observed.
The univariate and multivariate CR models without proportional odds gave
separate effects for each independent variable. Both univariate CR models
supported that the FIGO clinical stage did have a significant positive influence on
the surgical stage outcomes. Although the CR model without proportional odds
gave the lowest deviance and a low AIC statistic, this particular model showed
that information on the FIGO clinical stage had a higher influence on the patients
with surgical stage 2 compared to those with FIGO clinical stage 1.
We compared the odds ratios of the 3 multivariate models. The odds ratio,
according to Norton and Dowd (2018), is not an absolute number. In addition,
Norton and Dowd (2018) asserted that odds ratios are simple to compute and can
be applied to discrete and continuous explanatory variables. The odds ratios, as
Szumilas (2010) explained in her article, compare the relative odds of the response
(in our case, surgical stage), given exposure to explanatory variables of interest.
She further expounds that the odds ratios can ascertain whether a particular
exposure is a risk factor and compare the magnitude of various risk factors for the
specific response. The 95% odds ratios confidence intervals estimate the precision
of the odds ratios and are considered a substitute for the presence of statistical
significance when the null value (OR=1) is not overlapped. Low levels of precision
are indicated by large confidence intervals whereas high levels of precision are
indicated by small confidence intervals.
The FIGO clinical stage had a higher influence on women whose odds of having a
surgical stage greater than surgical stage 2 relative to being in surgical stage 2 (see
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Table 4.17). Though the results gave large confidence intervals indicative of low
precision, a statistically significant p-value (0.0349) and confidence intervals that
did not span the null value (OR=1) confirmed the result. The OR for the other 4
predictors showed decreased odds of having a surgical stage greater than surgical
stage 2 relative to being in surgical stage 2. Also, there was decreased odds of
having a surgical stage greater than surgical stage 1 relative to being in surgical
stage 1 with the confidence intervals for the 5 statistically significant predictors
spanning the null value (OR=1). Clearly, there was no statistical significance with
the regression coefficients having p-values at > 0.05. The likelihood chi-square
ratio test showed that the CR model without proportional odds (chi-square
p-value=0.0823) is adequate compared to the CR model with proportional odds.
The utilization of ordinal regression models enables significant independent
variables to be identified with their effect on the classification of patients into
surgical stages. The MLR model was utilized so as to compared the results when
the ordinal scales were assumed nominal and the surgical stage outcomes analyzed
as binary logistic regression. Based on the results from the univariate and
multivariate MLR models, the findings suggest that the FIGO clinical stage alone
could not adequately predict the surgical stage outcomes based on the p-values
being > 0.05 (see Table 4.3 and 4.4. By utilizing the multinom function,
Rodŕıguez (2019a) emphasized its simplicity and the fact that the function works
well with vector outcomes and factor predictor variables. The multinom function
chose the first response category as the reference category which was surgical stage
0 in our case. The MLR model was fitted in which the probability of each outcome
was estimated in one maximum likelihood procedure. Our findings concerning the
FIGO clinical stage in determining the surgical stage of a cervical cancer patient
was not sufficient enough to determine the surgical treatment option. With
reference to table 4.3, the univariate MLR model had a logistic coefficient of 2.66
showing that the FIGO clinical stage had more of a higher influence on
determining the classification into surgical stage 2 with a less and negative
influence noted on classification into surgical stage 1 which had a logistic
coefficient of −0.06 both being compared to the baseline category (surgical stage 0
). This is supported by a graphical effects display for the surgical stage which
apparently showed that the patients classified under surgical stage 2 were more
likely to have FIGO clinical stage 2 cervical cancer compared to FIGO clinical
stage 1 and patients classified under surgical stages 0 and 1 were less likely to have
FIGO clinical stage 2 cervical cancer compared to FIGO clinical stage 1. Our
findings were complimented by Gold et al. (2008) who stated that clinical staging
is only 60% accurate. However, the predictive approach demonstrated that the 5
predictors were not statistically significant in predicting the surgical stage
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outcomes.
In a study aimed at ascertaining the presence, distribution and metastatic
involvement of parametrial lymph nodes of patients undergoing radical
hysterectomy, Girardi et al. (1989) found a linear association between both the
FIGO clinical stage, tumor volume and the frequency of positive parametrial
lymph nodes. Moreover, with positive lymph nodes, the recurrence rate increased
and the survival rate dropped. The multivariate MLR model findings completely
ruled out the FIGO clinical stage as having any influence on classifying a patient
under surgical stage 1 (p-value=0.99441) versus surgical stage 0 and in contrast
having positive and significant influence on classifying a patient under surgical
stage 2 (p-value=0.02297) versus surgical stage 0. Although the presence of
parametrial involvement was not statistically significant, there were higher odds of
classifying a patient under surgical stage 2 versus surgical stage 0 when the FIGO
clinical stage was found to be statistically significant to predicting the surgical
stage outcome. Based on the inferential approach, FIGO clinical stage took
precedence as the key independent predictor. Unlike Girardi et al. (1989), the data
lacked sufficient information on tumor size and frequency of positive parametrial
lymph nodes; rather, our study had a binary outcome (yes/no) for the cancer
being involved with the parametrium.
The inferential approach conveyed that the ACL multivariate model without
proportional odds had the highest accuracy (70.67%[59.02% − 80.62%]). Based on
the inferential approach, both the univariate ACL models with and without
proportional odds support that the FIGO clinical stage has a significant effect on
the surgical stage outcomes. Based on the goodness-of-fit statistics, the
multivariate ACL model without proportional odds had the lowest deviance and
the highest log-likelihood ratio. It is intriguing to observe that the 5 predictors
were statistically insignificant on the probability of being classified under surgical
stage 1 versus surgical stage 0 and on the probability of being classified under
surgical stage 2 versus surgical stage 1.The FIGO clinical stage showed greater
influence on surgical stage outcomes in the ACL model with proportional odds.
Based on the multivariate ACL model without proportional odds, there was
decreased odds of being classified under surgical stage 1 versus surgical stage 0
among the women with FIGO clinical stage 2 compared to those with FIGO
clinical stage 1 with the OR confidence intervals displaying statistical
non-significance. In the case of being classified under surgical stage 1 versus
surgical stage 0, we noted decreased odds for all the predictors with the exception
of the presence of vaginal involvement (OR=1.43[0.06 − 34.47]) with low precision
and statistical non-significance. Similarly, we make out decreased odds of being
classified under surgical stage 2 versus surgical stage 1 among the women with
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FIGO clinical stage 2 compared to those with FIGO clinical stage 1 with the OR
confidence intervals displaying statistical non-significance. We noted that
decreased odds of being classified under surgical stage 2 versus surgical stage 1 for
all the predictors with the exception of symptomatic lower abdominal pain
(OR=1.39[0.19 − 10.39]) and symptomatic vaginal discharge
(OR=3.91[0.49 − 31.42]) with low precision and non-statistical significance. The
analysis confirms that the FIGO clinical stage is the key factor within the cervical
cancer setting when the gynecologists determine the suitability of the surgical
treatment therapy for women with confirmed invasive cancer.
In our study,the CR model without the proportional odds assumption was the best
fit compared to the CR model with proportional odds. Based on the comparison of
models, the work of Guzman-Castillo et al. (2015) compared the continuation ratio
model, the adjacent category model, the multinomial model and two other models
on the ordinal response of hospital length of stay with patient characteristics as
covariates. The ordinal regression model, the CR model and the ACL model
violated the proportional odds assumption. Moreover, in their article, Buch et al.
(2005) compared the estimated relative risks of the multinomial model, the
cumulative ratio model and the continuation ratio model on blood cancer ordinal
responses. The authors determined through the goodness-of-fit statistics, the
regression diagnostic analysis, small standard errors and smaller 95% confidence
intervals that the CR model was the best fit model for the ordinal responses. The
work of Dos Santos and Berridge (2000) expounded on the CR model as compared
to the ACL model and the baseline category model sharing that the CR model is
recognized for being a simple decomposition of a multinomial distribution, its
possession of the property of conditional independence between categories and the
model’s significance levels capability of being affected by a reversal in the order of
the categories. In addition, a prior study by Zhou et al. (2008) compared the fit of
the baseline category model, the proportional odds model and the adjacent
category model in determining the prostate cancer stage and found the baseline
category model to have the highest DIC. The authors took the investigation
further by comparing the baseline category model to a logistic regression model
fitted to dichotomized ordinal responses which demonstrated that the baseline
category model was a superior fit. de Jong et al. (2019) recommended that at least
50 multinomial events per variable. The author indicated that the MLR predictive
performance gradually improves as the number of multinomial events per variable
increases. Our study results show that this could be the possible reason for the
MLR model estimated by maximum likelihood being the most unlikely choice
among the 3 ordinal regression models.
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The Predictive Approach
The predictive approach utilized a larger sample size based on simulation and the
results showed that the 5 predictor variables were not statistically significant in
predicting the surgical stage outcomes for women with confirmed cervical cancer
prior to surgical treatment. The multivariate CR model without proportional
odds presented an AIC value of 13754.89 with the lowest deviance of 13730.89 and
highest log-likelihood ratio of −6865.44 indicating that it would be the best model
to select for the simulated cervical cancer data. In contrast, the predictive
approach demonstrated no similarity between the MLR and ACL model which
may be attributed to the large sample size utilized to train the models. Clearly,
this outcome was in contrast to the inferential approach that showed some
similarities between the 2 regression models. In order to test the proportional odds
assumption, the CR model and the ACL models were fitted with and without
proportional odds. The accuracy of the CR model without proportional odds was
66.78%. However, the goodness-of-fit statistics showed that the CR model without
proportional odds gave the lowest deviance of 13730.89 and a low AIC statistic of
13754.89. The predictive approach clearly demonstrated that the 5 predictor
variables were not statistically significant in predicting the surgical stage
outcomes. Clearly, there is need for collection of additional clinical and laboratory
data that can aid the development of predictive algorithms.
The 5 predictor variables gave odds ratios with confidence intervals that did span
the null value (OR = 1) demonstrating statistical non-significance. In contrast, the
odds ratio results gave small confidence intervals indicative of higher levels of
precision (see Table 4.38). The OR for vaginal involvement showed decreased
odds of having a surgical stage greater than surgical stage 1 relative to being in
surgical stage 1 and decreased odds of having a surgical stage greater than surgical
stage 2 relative to being in surgical stage 2. The OR for FIGO clinical stage and
parametrial involvement showed increased odds of having a surgical stage greater
than surgical stage 1 relative to being in surgical stage 1 and in contrast, decreased
odds of having a surgical stage greater than surgical stage 2 relative to being in
surgical stage 2.The OR for symptomatic vaginal discharge and symptomatic lower
abdominal pain showed decreased odds of having a surgical stage greater than
surgical stage 1 relative to being in surgical stage 1 and in contrast, increased odds
of having a surgical stage greater than surgical stage 2 relative to being in surgical
stage 2.
An accuracy of 66.78%[64.67% − 68.85%] was found for the ACL multivariate
model without proportional odds which was slightly lower than the ACL model
based on the inferential approach. We obtained similar accuracy for the MLR
multivariate model and CR model without proportional odds of 66.78%
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[CI:64.67%− 68.86%] and 66.87% [CI:64.67%− 68.85%] respectively.
An AUC provides the overall measure of performance across all possible
classification thresholds. The AUC value is considered scale invariant given that it
is not an absolute value but a measure of how well predictions are ranked.
Moreover, it measures the quality of the model’s predictions irrespective of the
chosen classification category. The AUC value has a range of 0− 1 with a value of
0.0 indicative of a model with 100.00% incorrect predictions and a very poor
measure of separability. A value of 1.0 is indicative of a model with 100.00%
correct predictions and a good measure of separability. We obtained AUC values
for the chosen multivariate MLR, CR model with PPO and ACL model without
PPO to be approximately 0.5 (see Table 4.46 Therefore, the AUC values obtained
indicate that our 3 predictive ordinal regression models of choice have no class
separation capabilities.
Gentry et al. (2015) reported that traditional modeling methods were often
unsuitable as they required the number of predictors to be smaller than the sample
size and the predictors to be independent. However, in his study, Gentry et al.
(2015) gave preference to penalized regression models for ordinal responses which
introduced bias into the models in exchange for reducing variability. Similar to our
study, Gentry et al. (2015) chose the log likelihood and AIC as the measures of the
relative quality of the statistical models with addition of the BIC statistic.The
author did extract parameter estimates at the point that minimized the AIC value.
Through these steps, Gentry et al. (2015) suggested that ordinal regression models
should be developed that would allow for the inclusion of non-penalized
covariates,covariates or both. The author stated that this can be applied to the
CR models or the ACL models. This can be an area for future research utilizing
data from the cervical cancer clinics.
5.3 Implications
Based on an inferential and predictive approach, the thesis presented the
comparison between 3 different regression models for ordinal data with respect to
the best fit model for our cervical cancer data. We found that the CR model
without proportional odds yielded better results due to the highest AIC and log
likelihood ratio and the lowest residual deviance. In addition, it is clear that based
on the inferential approach, the key prognostic factor associated with invasive
cervical cancer was the FIGO clinical stage which particularly, had a higher
influence on the surgical stage 2 outcomes compared to the lesser surgical stage
categories. Of all the 5 independent features selected for classifying the patients
into surgical stages, the FIGO clinical stage took precedence. However, the
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predictive approach showed that neither the FIGO clinical stage was not sufficient
to determine the surgical stage outcomes nor the remaining 4 predictors. Thus, we
realize that further clinical and laboratory parameters are required to achieve the
application of predictive algorithms at the oncology department at CCCDC.
Moreover, the predictive approach supports the need to utilize a large sample as it
incorporates more precision and leads to efficient odds ratios.
The study was limited by the fact that the cervical cancer data was not created for
the purpose of building statistical models thus was not sufficient and probably
lacked key predictors for the type of analysis carried out in our study. Thus, our
study demonstrates the need of databases with additional variables that could be
significant to determining the suitability of surgical treatment such as molecular
data, CT / MRI imaging information and HPV-DNA types. In addition, several
misclassifications may be attributed to the imbalanced and largely varying
category sizes particularly for surgical stages 1 and 2. Moreover, research and data
collection for predictive algorithms could introduce practical learning tools for the
medical students who undergo medical training at the Moi Teaching and Referral
hospital. The data was biased due to the dropping of incomplete records which left
a small sample for building the models. Also, data was simulated to test the
predictive capabilities of the models and statistical techniques were not utilized to
address the imbalanced nature of the data as well as missing data. Although 4
predictors were not found to be key prognostic factors for highly accurate
classifications in our models, future research utilizing data structured for
developing predictive models in the cervical cancer setting could yield better
results that could be integrated into the oncology system. Although actual data
was not utilized to validate the models, the fact that the CR model is strictly an
ordinal classifier supports what Chen (2012) reported that a strict and validated
ordinal classifier can more accurately predict the cancer stages (ordinal scales)
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